<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cholera - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Cholera</span>
        </nav>

        <header class="page-header">
            <h1>Cholera</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Infectious Disease</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0015766" target="_blank">
                        MONDO:0015766
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Bacterial Infection</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">9</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">14</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Genes</div>
            </div>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">9</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Cholera Toxin Binding and Uptake</div>
                
                <div class="item-desc">Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        intestinal epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002563" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        endocytosis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006897" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        retrograde vesicle-mediated transport
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006890" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">ERAD-mediated CTA1 Translocation</div>
                
                <div class="item-desc">The A1 enzymatic subunit of cholera toxin is unfolded by protein disulfide isomerase in the ER and hijacks the ER-associated degradation (ERAD) machinery to retro-translocate into the cytosol, where it refolds to become enzymatically active.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        intestinal epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002563" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        ERAD pathway
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030433" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Gsα ADP-Ribosylation</div>
                
                <div class="item-desc">Cytosolic CTA1 catalyzes ADP-ribosylation of the Gsα subunit (GNAS) using NAD+ as substrate, locking adenylyl cyclase in a constitutively active state.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        intestinal epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002563" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        adenylate cyclase-activating G protein-coupled receptor signaling pathway
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007189" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Cholera Toxin</div>
                
                <div class="item-desc">Vibrio cholerae produces a toxin that activates adenylate cyclase in intestinal epithelial cells, leading to increased cyclic AMP (cAMP) levels.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        intestinal epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002563" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8783505" target="_blank">PMID:8783505</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Vibrio cholerae produce a variety of extracellular products that have deleterious effects on eukaryotic cells... CT acts by activation of adenylate cyclase-cAMP system located at the basolateral membrane of intestinal epithelial cells."</div>
                
                
                <div class="evidence-explanation">The statement is supported by the information that cholera toxin (CT) from Vibrio cholerae activates the adenylate cyclase-cAMP system in intestinal epithelial cells.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30624615" target="_blank">PMID:30624615</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR)."</div>
                
                
                <div class="evidence-explanation">The statement is supported as it describes CT inducing diarrhea through cAMP-mediated mechanisms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/4364505" target="_blank">PMID:4364505</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Comparable results were also obtained when cholera toxin was used. The degree of enzyme stimulation was proportional to the concentration of enterotoxin."</div>
                
                
                <div class="evidence-explanation">This further confirms that cholera toxin stimulates adenylate cyclase activity in cells.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Increased cAMP</div>
                
                <div class="item-desc">Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        intestinal epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002563" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cAMP-mediated signaling
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0019933" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        chloride transmembrane transport
                        
                        <a href="http://purl.obolibrary.org/obo/GO_1902476" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23651092" target="_blank">PMID:23651092</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Increased intracellular cAMP in human intestinal epithelial cells accounts for pathogenesis of profuse diarrhea and severe fluid loss in cholera"</div>
                
                
                <div class="evidence-explanation">This reference directly supports the statement by confirming that elevated cAMP levels in intestinal epithelial cells lead to the secretion of fluid, resulting in profuse diarrhea, which aligns with the described pathophysiology.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30624615" target="_blank">PMID:30624615</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR)."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by explaining that CT-induced diarrhea involves cAMP-mediated chloride secretion, leading to diarrhea.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/80378" target="_blank">PMID:80378</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Cholera toxin causes net secretion of fluid into the small intestine of weanling pigs, and secretory rates are dependent on the dose of the toxin placed in intestinal loops."</div>
                
                
                <div class="evidence-explanation">While this study supports that cholera toxin leads to fluid secretion, it notes that net fluid fluxes did not always correlate with total mucosal cAMP concentrations in pigs. Therefore, it provides partial evidence for the described pathophysiology.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Profuse Watery Diarrhea</div>
                
                <div class="item-desc">Rapid loss of fluids and electrolytes through diarrhea, which can lead to severe dehydration and hypovolemic shock.</div>
                
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14738797" target="_blank">PMID:14738797</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."</div>
                
                
                <div class="evidence-explanation">The statement describes the loss of large volumes of fluids and electrolytes through diarrhea, leading to severe dehydration and hypovolemic shock, which aligns with the literature.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15367740" target="_blank">PMID:15367740</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal."</div>
                
                
                <div class="evidence-explanation">The literature describes large fluid losses and severe dehydration due to cholera, supporting the statement&#39;s explanation of pathophysiology.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28448489" target="_blank">PMID:28448489</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"To take advantage of emerging opportunities to reduce morbidity and mortality from diarrheal disease, we need to better understand the determinants of life-threatening severe dehydration (SD) in resource-poor settings."</div>
                
                
                <div class="evidence-explanation">The text mentions severe dehydration as a key issue in the pathophysiology of cholera.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Colonization and Biofilm Formation</div>
                
                <div class="item-desc">V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        intestinal epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002563" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        biofilm formation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042710" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        bacterial adhesion to host
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0044406" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Accessory Toxins and Virulence Factors</div>
                
                <div class="item-desc">V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        intestinal epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002563" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        disruption of cells of other organism
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0044364" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        tight junction organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0120193" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Host Metabolic Reprogramming</div>
                
                <div class="item-desc">Cholera toxin-driven signaling reprograms host epithelial metabolism, leading to release of host-derived nutrients (long-chain fatty acids, lactate, glycerol) into the intestinal lumen that fuel V. cholerae growth and enhance transmission.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        intestinal epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002563" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        regulation of lipid metabolic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0019216" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">⬡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Dehydration[&#34;Dehydration&#34;]
    ERAD_mediated_CTA1_Translocation[&#34;ERAD-mediated CTA1 Translocation&#34;]
    Shock[&#34;Shock&#34;]
    Tachycardia[&#34;Tachycardia&#34;]
    Acute_Kidney_Injury[&#34;Acute Kidney Injury&#34;]
    Profuse_Watery_Diarrhea[&#34;Profuse Watery Diarrhea&#34;]
    Cholera_Toxin[&#34;Cholera Toxin&#34;]
    Low_Blood_Pressure[&#34;Low Blood Pressure&#34;]
    Gsα_ADP_Ribosylation[&#34;Gsα ADP-Ribosylation&#34;]
    Sunken_Eyes[&#34;Sunken Eyes&#34;]
    Severe_Dehydration[&#34;Severe Dehydration&#34;]
    Cholera_Toxin_Binding_and_Uptake[&#34;Cholera Toxin Binding and Uptake&#34;]
    Increased_cAMP[&#34;Increased cAMP&#34;]

    Cholera_Toxin_Binding_and_Uptake --&gt; ERAD_mediated_CTA1_Translocation
    ERAD_mediated_CTA1_Translocation --&gt; Gsα_ADP_Ribosylation
    Gsα_ADP_Ribosylation --&gt; Increased_cAMP
    Cholera_Toxin --&gt; Increased_cAMP
    Increased_cAMP --&gt; Profuse_Watery_Diarrhea
    Profuse_Watery_Diarrhea --&gt; Severe_Dehydration
    Profuse_Watery_Diarrhea --&gt; Shock
    Dehydration --&gt; Sunken_Eyes
    Dehydration --&gt; Low_Blood_Pressure
    Dehydration --&gt; Tachycardia
    Dehydration --&gt; Sunken_Eyes
    Dehydration --&gt; Low_Blood_Pressure
    Dehydration --&gt; Tachycardia
    Dehydration --&gt; Acute_Kidney_Injury

    style Dehydration fill:#fef3c7
    style ERAD_mediated_CTA1_Translocation fill:#dbeafe
    style Shock fill:#fef3c7
    style Tachycardia fill:#fef3c7
    style Acute_Kidney_Injury fill:#fef3c7
    style Profuse_Watery_Diarrhea fill:#fef3c7
    style Cholera_Toxin fill:#dbeafe
    style Low_Blood_Pressure fill:#fef3c7
    style Gsα_ADP_Ribosylation fill:#dbeafe
    style Sunken_Eyes fill:#fef3c7
    style Severe_Dehydration fill:#fef3c7
    style Cholera_Toxin_Binding_and_Uptake fill:#dbeafe
    style Increased_cAMP fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">14</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(5)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Eye<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Genitourinary<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Metabolism<span class="pill-count">(5)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Musculoskeletal<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Other<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">5</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hypovolemic Shock
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0031274" target="_blank">
                                Hypovolemic shock
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0031274)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Caused by severe dehydration due to fluid loss</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33252133" target="_blank">PMID:33252133</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement. In the following case... he was suffering from cholera. On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock."</div>
                
                
                <div class="evidence-explanation">This case description demonstrates that hypovolemic shock is an occasional systemic consequence of cholera due to excessive fluid loss.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14738797" target="_blank">PMID:14738797</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."</div>
                
                
                <div class="evidence-explanation">This abstract highlights that severe dehydration caused by cholera often leads to shock, supporting the claim.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hypovolemic Shock
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0031274" target="_blank">
                                Hypovolemic shock
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0031274)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Caused by severe dehydration due to fluid loss</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14738797" target="_blank">PMID:14738797</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."</div>
                
                
                <div class="evidence-explanation">The reference states that cholera leads to severe dehydration and shock, which aligns with the statement indicating that cholera can occasionally cause hypovolemic shock due to severe dehydration.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/4869291" target="_blank">PMID:4869291</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hemodynamic studies on cholera. Effects of hypovolemia and acidosis."</div>
                
                
                <div class="evidence-explanation">The title of the reference suggests that hypovolemia, which can lead to hypovolemic shock, is a significant effect of cholera.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33252133" target="_blank">PMID:33252133</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement."</div>
                
                
                <div class="evidence-explanation">The reference confirms that cholera causes hypovolemia, which can lead to hypovolemic shock, supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Shock
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0031273" target="_blank">
                                Shock
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0031273)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Low Blood Pressure
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002615" target="_blank">
                                Hypotension
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002615)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Tachycardia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001649" target="_blank">
                                Tachycardia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001649)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Eye
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Sunken Eyes
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000490" target="_blank">
                                Deeply set eye
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000490)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Genitourinary
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Acute Kidney Injury
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001919" target="_blank">
                                Acute kidney injury
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001919)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Metabolism
                    <span class="cat-count">5</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Dehydration
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001944" target="_blank">
                                Dehydration
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001944)</span>
                        </span>
                        
                    </div>
                    
                    
                    <div class="item-meta">
                        <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Sunken Eyes</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Low Blood Pressure</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Tachycardia</span>
                        
                    </div>
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28448489" target="_blank">PMID:28448489</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Vibrio cholerae was the most common pathogen isolated (12,405 patients; 22%), and had the strongest association with SD (AOR 4.77; 95% CI: 4.41-5.51)."</div>
                
                
                <div class="evidence-explanation">The article notes that Vibrio cholerae was the most common pathogen with a strong association with severe dehydration, which aligns with the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15367740" target="_blank">PMID:15367740</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal."</div>
                
                
                <div class="evidence-explanation">The study discusses severe dehydration, but also mentions metabolic and respiratory complications without specifically noting frequency.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33252133" target="_blank">PMID:33252133</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"It was later confirmed that he was suffering from cholera. On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock."</div>
                
                
                <div class="evidence-explanation">This article discusses a specific case of cholera leading to severe dehydration and hypovolemic shock, but does not provide frequency data.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Dehydration
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001944" target="_blank">
                                Dehydration
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001944)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Can lead to death within hours if untreated</div>
                    
                    
                    <div class="item-meta">
                        <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Sunken Eyes</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Low Blood Pressure</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Tachycardia</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Acute Kidney Injury</span>
                        
                    </div>
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34523840" target="_blank">PMID:34523840</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A 28-year-old female presented with severe dehydration due to acute diarrhea and vomiting, which she developed after returning from a vacation in Togo"</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by describing a case of severe dehydration due to cholera, highlighting its systemic nature and the rapid onset of severe symptoms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31668817" target="_blank">PMID:31668817</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Cholera still affects about three million people a year and kills approximately 100,000. Cholera can be effectively managed in the majority of cases with oral rehydration solution alone. Up to one third of patients present with severe dehydration, which can be diagnosed clinically, and will..."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by noting that severe dehydration is a common and critical condition in cholera patients, which can lead to death if untreated.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33252133" target="_blank">PMID:33252133</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement."</div>
                
                
                <div class="evidence-explanation">This reference supports the systemic impact of cholera, including dehydration, which can lead to severe complications and death.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hypokalemia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002900" target="_blank">
                                Hypokalemia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002900)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/5300879" target="_blank">PMID:5300879</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hypokalaemic patterns were seen in 40% of the cases in the acute stage (during rehydration). This pattern became more marked after rehydration and disappeared gradually within 3-7 days."</div>
                
                
                <div class="evidence-explanation">The study indicates that hypokalemia is a frequent occurrence in cholera patients, particularly during the acute stage and rehydration process.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33252133" target="_blank">PMID:33252133</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock."</div>
                
                
                <div class="evidence-explanation">This case report mentions hyperkalemia in a cholera patient, not hypokalemia. Therefore, it does not support the statement about frequent hypokalemia in cholera.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28957470" target="_blank">PMID:28957470</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Severe cholera is a life-threatening illness of hypovolemic shock and metabolic acidosis due to rapid and profuse diarrheal fluid loss. Emergency life-saving therapy is i.v. saline, optionally supplemented with potassium and alkali to correct the fluid deficit, potassium losses and acidosis."</div>
                
                
                <div class="evidence-explanation">The reference mentions potassium losses as part of the treatment for severe cholera, which indirectly suggests hypokalemia might occur, but it does not provide direct evidence of its frequency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Metabolic Acidosis
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001942" target="_blank">
                                Metabolic acidosis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001942)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15367740" target="_blank">PMID:15367740</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal. A detailed analysis emphasizing principles of physiology and a quantitative..."</div>
                
                
                <div class="evidence-explanation">The study discusses the presence of metabolic acidosis in a cholera patient, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33252133" target="_blank">PMID:33252133</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement."</div>
                
                
                <div class="evidence-explanation">Electrolyte derangement in cholera can lead to conditions like metabolic acidosis, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/5697815" target="_blank">PMID:5697815</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Oral maintenance of water-electrolyte and acid-base balance in cholera: a preliminary report."</div>
                
                
                <div class="evidence-explanation">The mention of acid-base balance in cholera suggests a frequent occurrence of metabolic acidosis, supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Severe Dehydration
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001944" target="_blank">
                                Dehydration
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001944)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Musculoskeletal
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Muscle Cramps
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0003394" target="_blank">
                                Muscle spasm
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0003394)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Due to electrolyte imbalances</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33252133" target="_blank">PMID:33252133</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock."</div>
                
                
                <div class="evidence-explanation">The case study mentions muscle cramping as a symptom in a patient with cholera, but does not explicitly link it to electrolyte imbalances.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29857264" target="_blank">PMID:29857264</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Literature analysis indicates that neuromuscular hypothesis may prevails over the initial hypothesis of the dehydration as the trigger event of muscle cramps."</div>
                
                
                <div class="evidence-explanation">This review focuses on the neuromuscular hypothesis for muscle cramps and does not provide evidence linking muscle cramps to electrolyte imbalances specifically in cholera.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9694423" target="_blank">PMID:9694423</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Cramps occur during or after exercise regardless of whether the exercise is performed in the heat or the cold, or in water."</div>
                
                
                <div class="evidence-explanation">The review discusses muscle cramps in the context of exercise and heat illness, but does not relate it to cholera or electrolyte imbalances.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Profuse Watery Diarrhea
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                    </div>
                    
                    
                    <div class="item-meta">
                        <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Severe Dehydration</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Shock</span>
                        
                    </div>
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14738797" target="_blank">PMID:14738797</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."</div>
                
                
                <div class="evidence-explanation">The provided excerpt supports the statement that profuse watery diarrhea is a very frequent diagnostic phenotype of cholera and that it leads to severe dehydration and shock.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34523840" target="_blank">PMID:34523840</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Her stool was watery, with flecks of mucous, also referred to as &#39;rice-water&#39; stool, which is typical for cholera and can amount to 1000 cc/hour."</div>
                
                
                <div class="evidence-explanation">This case study supports the characterization of profuse watery diarrhea as a very frequent diagnostic phenotype of cholera.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29488455" target="_blank">PMID:29488455</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Adding dehydration, vomiting, or rice water stools to the case definition could increase the specificity without a substantial decrease in sensitivity."</div>
                
                
                <div class="evidence-explanation">This study supports that rice-water stools (a form of profuse watery diarrhea) are indicative of cholera and frequently used in its diagnosis.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Oral Rehydration Solution (ORS)
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000458" target="_blank">
                            MAXO:0000458
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Mixture of clean water, salt, and sugar to replace lost fluids and electrolytes.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8783513" target="_blank">PMID:8783513</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"For more than two decades, WHO and UNICEF have recommended a single formulation of oral rehydration salts (ORS) solution based on glucose and three salts. This product has proven safe and highly effective in treating and preventing dehydration from diarrhoea of all causes and in all age groups..."</div>
                
                
                <div class="evidence-explanation">The use of Oral Rehydration Solution (ORS) is supported as a treatment for cholera, as it involves a mixture of water, salts, and glucose to replace lost fluids and electrolytes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/49561" target="_blank">PMID:49561</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The data contrast with the rarity of treatment failures of oral glucose-electrolyte solutions. Glucose, therefore, is preferable to sucrose for oral therapy of diarrhoeal diseases."</div>
                
                
                <div class="evidence-explanation">This study emphasizes the effectiveness of glucose-based ORS over sucrose, supporting the use of ORS with clean water, salt, and glucose as a treatment for cholera and related diarrheal diseases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12562304" target="_blank">PMID:12562304</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The mainstay of therapy of cholera patients is rehydration with oral rehydration salt solution or intravenous Ringer&#39;s lactate depending upon the degree of dehydration."</div>
                
                
                <div class="evidence-explanation">This reference affirms that ORS is a primary treatment method for cholera, consistent with the use of clean water, salt, and sugar to replace lost fluids and electrolytes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Intravenous Rehydration
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000458" target="_blank">
                            MAXO:0000458
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Used for severe dehydration when rapid fluid replacement is necessary.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8736618" target="_blank">PMID:8736618</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients with severe dehydration should be treated intravenously, as should those patients who do not tolerate oral rehydration solution (ORS)."</div>
                
                
                <div class="evidence-explanation">The literature clearly states that intravenous rehydration is used for severe dehydration in cholera patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3171790" target="_blank">PMID:3171790</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We compared the efficacy and safety of a single polyelectrolyte solution, Dhaka solution (DS), containing 133 mmol/L sodium, 13 mmol/L potassium, 98 mmol/L chloride, and 48 mmol/L acetate with and without 139 mmol/L (25 gm/L) dextrose in the rapid (4 hours) rehydration of 67 patients with..."</div>
                
                
                <div class="evidence-explanation">The study supports the use of intravenous rehydration for moderate or severe dehydration, which includes severe dehydration caused by cholera.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35465904" target="_blank">PMID:35465904</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Fluid therapy is the most important therapeutic measure in patients suffering from dehydration or hypovolemia owing to gastrointestinal diseases. The therapy should be tailored based on the patient&#39;s condition, physical examination, and diagnostic findings."</div>
                
                
                <div class="evidence-explanation">The literature discusses the importance of fluid therapy for dehydration but does not explicitly focus on intravenous rehydration for severe dehydration in cholera patients.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Antibiotics
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Shorten the course of the illness and reduce the severity, examples include doxycycline, azithromycin.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24944120" target="_blank">PMID:24944120</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Overall, antimicrobial therapy shortened the mean duration of diarrhoea by about a day and a half compared to placebo or no treatment (MD -36.77 hours, 95% CI -43.51 to -30.03, 19 trials, 1013 participants, moderate quality evidence). Antimicrobial therapy also reduced the total stool volume by..."</div>
                
                
                <div class="evidence-explanation">The reference indicates that antimicrobial treatment, including antibiotics like doxycycline and azithromycin, significantly shortens the duration of diarrhea and reduces stool volume, thereby supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11378428" target="_blank">PMID:11378428</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Antibiotics such as tetracycline and doxycycline shorten the duration of illness but do not significantly affect overall mortality."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement as it specifies that antibiotics such as doxycycline shorten the illness duration, aligning with the value description.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Zinc Supplementation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000106" target="_blank">
                            MAXO:0000106
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Recommended for children to reduce the duration and severity of diarrhea.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18184631" target="_blank">PMID:18184631</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Zinc supplementation significantly reduced the duration of diarrhoea and stool output in children with cholera. Children with cholera should be supplemented with zinc to reduce its duration and severity."</div>
                
                
                <div class="evidence-explanation">This study found that zinc supplementation reduced both the duration and severity of diarrhoea in children with cholera.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17582575" target="_blank">PMID:17582575</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Short-course daily zinc supplementation shortens the duration (a 15%-24% reduction) and severity of the episode and is now recommended for the treatment of all episodes of diarrhea occurring among children &lt;5 years of age."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by recommending zinc supplementation to reduce the duration and severity of diarrhea in children under 5 years of age.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30269306" target="_blank">PMID:30269306</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Zinc supplements are recommended in children with acute infectious diarrhea."</div>
                
                
                <div class="evidence-explanation">This guideline recommends zinc supplementation specifically for children with acute infectious diarrhea.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Vaccination
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001017" target="_blank">
                            MAXO:0001017
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Oral cholera vaccines can provide protection in endemic areas or during outbreaks.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22634452" target="_blank">PMID:22634452</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This vaccine should be used in areas where cholera is endemic, particularly in those at risk of outbreaks, in conjunction with other prevention and control strategies."</div>
                
                
                <div class="evidence-explanation">This supports that oral cholera vaccines can provide protection in endemic areas or during outbreaks.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15193408" target="_blank">PMID:15193408</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Retrospective analysis suggests that mass vaccination with oral cholera vaccines can be a useful adjunct tool for controlling outbreaks, particularly if implemented early in association with other standard control measures."</div>
                
                
                <div class="evidence-explanation">This indicates that oral cholera vaccines can be a valuable tool during outbreaks.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36255170" target="_blank">PMID:36255170</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Efficacies of the currently licensed cholera vaccines are not optimal in endemic settings and low in children below the age of five, a section of the population most susceptible to the disease."</div>
                
                
                <div class="evidence-explanation">While oral cholera vaccines can provide protection, their efficacy is not optimal in endemic settings, especially for children under five.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Contaminated Water</div>
                
                <div class="item-desc">Major source of infection</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29949592" target="_blank">PMID:29949592</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We concluded that this cholera outbreak was caused by drinking lake water collected from inside the lakeshore water-collection site X."</div>
                
                
                <div class="evidence-explanation">This study explicitly identifies contaminated water as the source of a cholera outbreak.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33844507" target="_blank">PMID:33844507</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Cholera is transmitted primarily by the ingestion of drinking water contaminated with fecal matter..."</div>
                
                
                <div class="evidence-explanation">This review supports the statement that contaminated water is a major environmental source of cholera infection.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37930488" target="_blank">PMID:37930488</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"...acute diarrheal disease (ADD), typhoid, cholera, hepatitis, and shigellosis are common waterborne diseases in India."</div>
                
                
                <div class="evidence-explanation">The abstract indicates that cholera is one of the primary diseases transmitted through contaminated water in India.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Poor Sanitation</div>
                
                <div class="item-desc">Facilitates the spread of the bacteria</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30512613" target="_blank">PMID:30512613</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Prevention is based on universal access to water, sanitation and hand hygiene."</div>
                
                
                <div class="evidence-explanation">The snippet suggests that poor sanitation is linked to cholera and can help prevent its spread with proper sanitation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20074356" target="_blank">PMID:20074356</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In both pre- and post-monsoon seasons, SES significantly influences these patterns, likely because it is a proxy for poor water quality and sanitation in poorer households."</div>
                
                
                <div class="evidence-explanation">The snippet implies that poor sanitation is a significant factor influencing cholera patterns.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34961483" target="_blank">PMID:34961483</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Drinking contaminated water from an unprotected well was associated with this cholera outbreak."</div>
                
                
                <div class="evidence-explanation">The outbreak was associated with poor sanitation practices involving unprotected water sources.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Electrolytes
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Low Sodium, Potassium, and Bicarbonate Levels)</span>
                    
                </div>
                
                <div class="item-desc">Context: Due to excessive loss in diarrhea</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28957470" target="_blank">PMID:28957470</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Emergency life-saving therapy is i.v. saline, optionally supplemented with potassium and alkali to correct the fluid deficit, potassium losses and acidosis."</div>
                
                
                <div class="evidence-explanation">The article suggests the need to correct potassium losses and acidosis, which supports low potassium and bicarbonate levels, but there is no specific mention of sodium levels.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15367740" target="_blank">PMID:15367740</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal."</div>
                
                
                <div class="evidence-explanation">This reference discusses bicarbonate losses due to diarrhea, supporting low bicarbonate levels but does not provide direct evidence for sodium and potassium levels.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/5300879" target="_blank">PMID:5300879</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hypokalaemic patterns were seen in 40% of the cases in the acute stage (during rehydration)."</div>
                
                
                <div class="evidence-explanation">The study reports hypokalemia in cholera patients, which supports low potassium levels, but it doesn&#39;t provide information about sodium and bicarbonate levels.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Cholera
creation_date: &#39;2025-12-04T16:57:31Z&#39;
updated_date: &#39;2026-01-11T03:03:01Z&#39;
category: Infectious Disease
parents:
- Bacterial Infection
infectious_agent:
- name: Vibrio cholerae
  infectious_agent_term:
    preferred_term: Vibrio cholerae
    term:
      id: NCBITaxon:666
      label: Vibrio cholerae
  description: A bacterium that causes severe diarrhea by producing a toxin that triggers excess water and electrolyte loss in the intestines.
  has_subtypes:
  - name: O1
    description: Classical and El Tor biotypes
  - name: O139
  evidence:
  - reference: PMID:30512613
    supports: SUPPORT
    snippet: Cholera is caused by Vibrio cholerae, a Gram-negative bacteria. Some strains can synthesize an enterotoxin - the cholera toxin - which is responsible for the disease.
    explanation: This reference supports that Cholera is caused by a bacterium, Vibrio cholerae, which produces a toxin leading to severe diarrhea.
  - reference: PMID:21880975
    supports: SUPPORT
    snippet: &#39;Vibrio cholerae serogroup O1, the causative agent of the diarrheal disease cholera, is divided into two biotypes: classical and El Tor. Both biotypes produce the major virulence factors toxin-coregulated pilus (TCP) and cholera toxin (CT).&#39;
    explanation: This reference supports the existence of Classical and El Tor biotypes under the O1 serogroup of Vibrio cholerae.
  - reference: PMID:17716938
    supports: SUPPORT
    snippet: The bacterial protein toxin of Vibrio cholerae, cholera toxin, is a major agent involved in severe diarrhoeal disease.
    explanation: This reference confirms that the cholera toxin produced by Vibrio cholerae is responsible for severe diarrhea.
  - reference: PMID:27222028
    supports: SUPPORT
    snippet: Cholera is caused by infection with Vibrio cholerae.
    explanation: This reference supports the statement that Vibrio cholerae causes cholera.
  - reference: PMID:34586051
    supports: SUPPORT
    snippet: Vibrio cholerae O1 is the aetiological agent of the severe diarrhoeal disease cholera.
    explanation: This reference supports that Vibrio cholerae O1 is a subtype that causes cholera.
transmission:
- name: Fecal-Oral Transmission
  description: Spread through ingestion of contaminated water or food.
  evidence:
  - reference: PMID:10892490
    supports: SUPPORT
    snippet: Cholera is a highly contagious disease, and is transmitted primarily by ingestion of faecally-contaminated water by susceptible persons. Besides water, foods have also been recognized as an important vehicle for transmission of cholera.
    explanation: This statement supports the idea that cholera is spread through ingesting contaminated water or food and aligns with the principle of fecal-oral transmission.
  - reference: PMID:36634024
    supports: SUPPORT
    snippet: Cholera, which is transmitted through ingestion of water or food contaminated with fecal matter...
    explanation: This explicitly states that cholera is transmitted via ingestion of contaminated water or food, supporting the idea of fecal-oral transmission.
  - reference: PMID:36573678
    supports: SUPPORT
    snippet: Cholera is a diarrheal infection caused by ingested water or food contaminated with the bacterium Vibrio cholerae.
    explanation: This reference supports the transmission of cholera through contaminated water or food, aligning with fecal-oral transmission.
  - reference: PMID:33753586
    supports: SUPPORT
    snippet: This ADD outbreak was likely associated with drinking contaminated groundwater, which probably occurred after heavy rainfall in an area of open defecation.
    explanation: This suggests that contaminated water, a route fitting fecal-oral transmission, was a primary factor in the outbreak, supporting the statement.
- name: Direct Contact
  description: Can spread through direct contact with infected individuals or their bodily fluids.
  evidence:
  - reference: PMID:2341728
    supports: SUPPORT
    snippet: Extensive epidemiological investigations showed that the organism was not transmitted by contaminated food or water but through close person-to-person contact.
    explanation: This study reports an outbreak of cholera caused by Vibrio cholerae O1 in a psychiatric hospital in Singapore and demonstrates that the transmission occurred through close person-to-person contact.
  - reference: PMID:25411971
    supports: SUPPORT
    snippet: Significant direct transmission (p-value&lt;0.0001) occurred among 1414 members of 364 households.
    explanation: This study demonstrates a significant role of direct transmission within households during cholera outbreaks in Bangladesh.
  - reference: PMID:30512613
    supports: SUPPORT
    snippet: Contamination is by ingestion, due to close contact with a patient, or by contaminated water and food.
    explanation: This reference mentions that close contact with a patient can result in contamination and transmission of cholera.
  - reference: PMID:29174695
    supports: SUPPORT
    snippet: Cholera is known to be transmitted from person to person.
    explanation: The study discusses the transmission of cholera from person to person in endemic settings.
- name: Environmental Reservoirs
  description: Vibrio cholerae can survive in aquatic environments, potentially leading to outbreaks.
  evidence:
  - reference: PMID:31285087
    supports: SUPPORT
    snippet: While the bacteria can be isolated from both clinical and environmental sources during epidemics, it evades isolation by conventional culture techniques during the period between successive epidemics.
    explanation: The literature confirms that Vibrio cholerae can survive in aquatic environments during inter-epidemic periods and discusses the role of environmental reservoirs in cholera transmission.
  - reference: PMID:28642796
    supports: SUPPORT
    snippet: Altogether, 120 samples (60 water and 60 sediment samples) collected from ten sites on the river (January and February 2014) were analysed using PCR. Of the 120 samples, 37 sediment and 31 water samples were positive for at least one of the genes investigated.
    explanation: The presence of Vibrio cholerae in riverbed sediments suggests environmental reservoirs can harbor the bacteria and contribute to outbreaks.
  - reference: PMID:26488620
    supports: SUPPORT
    snippet: The environmental compartment, which serves as a source of exposure to toxigenic V. cholerae, is also modeled separately based on the biology of causative bacterium, the shedding of V. cholerae O1 by humans into the environment, as well as the effects of precipitation and water temperature on the concentration and survival of V. cholerae in aquatic reservoirs.
    explanation: The mathematical model incorporates the role of environmental reservoirs in cholera transmission and highlights their significance in maintaining the presence of Vibrio cholerae.
prevalence:
- population: Global
  percentage: Variable, higher in regions with poor sanitation
  evidence:
  - reference: PMID:22461716
    supports: SUPPORT
    snippet: The percentages of the population in each country that lacked access to improved sanitation were used to compute the populations at risk for cholera.
    explanation: The study links the risk of cholera to the lack of improved sanitation, supporting the statement that cholera prevalence is higher in regions with poor sanitation.
  - reference: PMID:36639850
    supports: SUPPORT
    snippet: Cholera transmission is associated with several socio-economic and environmental factors, each associated variable is suggested to have at least one mediating mechanism.
    explanation: The review highlights the influence of socio-economic factors like sanitation on cholera transmission, supporting the statement.
- population: South Asia (particularly Bangladesh and India)
  percentage: Endemic
  evidence:
  - reference: PMID:34550374
    supports: SUPPORT
    snippet: in many developing nations such as India, cholera disease is endemic.
    explanation: The reference clearly indicates that cholera is endemic in India, a part of South Asia.
  - reference: PMID:34633491
    supports: SUPPORT
    snippet: Cholera has been endemic to the Ganges Delta for centuries. Although the causative agent, Vibrio cholerae, is autochthonous to coastal and brackish water, cholera occurs continually in Dhaka, the inland capital city of Bangladesh which is surrounded by fresh water.
    explanation: The reference indicates that cholera is endemic in the Ganges Delta, which is part of South Asia, and it specifically mentions Dhaka, Bangladesh.
  - reference: PMID:34453539
    supports: SUPPORT
    snippet: In 2014, Bangladesh established a nationwide, facility-based cholera surveillance system for Vibrio cholerae infection... The cholera surveillance system in Bangladesh has the ability to monitor progress towards cholera elimination goals.
    explanation: The reference mentions the ongoing surveillance and control measures in Bangladesh, implicitly supporting the idea of cholera being endemic and prevalent in the region.
  - reference: PMID:20562706
    supports: SUPPORT
    snippet: The mechanisms underlying the seasonality of cholera are still not fully understood, despite long-standing recognition of clear bimodal seasonality in Bangladesh.
    explanation: This reference supports the statement by acknowledging the long-standing endemicity and seasonal patterns of cholera in Bangladesh.
- population: Parts of Africa
  percentage: Endemic
  evidence:
  - reference: PMID:24827501
    supports: PARTIAL
    snippet: More than 40 years after its resurgence in Africa in 1970, cholera remains a grave public health problem, characterized by large disease burden, frequent outbreaks, persistent endemicity, and high CFRs, particularly in the region of the central African Great Lakes which might act as reservoirs for cholera
    explanation: The reference supports that cholera is a persistent endemic problem in parts of Africa (e.g., Central African Great Lakes) and accounts for a significant portion of global cases and deaths. However, it does not specify the exact percentage of the population in Africa that is affected.
- population: Haiti
  percentage: Endemic
  evidence:
  - reference: PMID:37610182
    supports: SUPPORT
    snippet: In Haiti in 2017, the prevalence of serum vibriocidal antibody titers against Vibrio cholerae serogroup O1 among adults was 12.4% in Cerca-la-Source and 9.54% in Mirebalais.
    explanation: The data indicates a high prevalence of recent infection, suggesting cholera is prevalent among the endemic population in Haiti.
  - reference: PMID:23301694
    supports: SUPPORT
    snippet: Within days after detection, the Ministry of Public Health and Population established a National Cholera Surveillance System (NCSS)... Through October 20, 2012, the public health ministry reported 604,634 cases of infection, 329,697 hospitalizations, and 7436 deaths from cholera.
    explanation: The large number of reported cases indicates a significant prevalence of cholera in Haiti.
  - reference: PMID:33350917
    supports: SUPPORT
    snippet: Centre Department, Haiti, was the origin of a major cholera epidemic during 2010-2019.
    explanation: The outbreak in Haiti&#39;s Centre Department signifies a high prevalence of cholera within the endemic population over a considerable period.
  - reference: PMID:35259956
    supports: SUPPORT
    snippet: We also show that, in our model, effective reproduction numbers and epidemicity indices are explicitly related. Therefore, providing an upper bound to the effective reproduction number (significantly lower than the unit threshold) warrants negative epidemicity and, in turn, a rapidly fading outbreak preventing coalescence of sparse local sub-threshold flare-ups.
    explanation: The discussion on controlling the cholera spread through negative epidemicity indicates efforts to manage the disease prevalence.
  - reference: PMID:37735743
    supports: SUPPORT
    snippet: The 2010 cholera epidemic in Haiti was thought to have ended in 2019, and the Prime Minister of Haiti declared the country cholera-free in February 2022. On September 25, 2022, cholera cases were again identified in Port-au-Prince.
    explanation: Re-emergence of cases suggests ongoing cholera prevalence even after being declared cholera-free.
epidemiology:
- name: Basic Reproduction Number (R0)
  description: The average number of secondary infections caused by one infected individual in a completely susceptible population.
  minimum_value: 1
  maximum_value: 20
  notes: Highly variable depending on environmental and population factors. Higher in areas with poor sanitation and during initial outbreak phases.
  factors:
  - Population density
  - Sanitation conditions
  - Water quality
  - Hygiene practices
  evidence:
  - reference: PMID:21860658
    supports: NO_EVIDENCE
    snippet: R(0) has been widely used as a measure of disease strength to estimate the effectiveness of control measures and to form the backbone of disease-management policy.
    explanation: The abstract discusses the use of R0 in understanding disease spread but does not detail specific values or factors affecting R0 for cholera.
  - reference: PMID:22937199
    supports: NO_EVIDENCE
    snippet: The two most distinguishing epidemiologic features of the disease are its tendency to appear in explosive outbreaks and its predisposition to causing pandemics.
    explanation: The abstract provides an overview of cholera&#39;s epidemiology but does not mention specific R0 values or the factors affecting R0.
  - reference: PMID:36654005
    supports: PARTIAL
    snippet: the basic reproduction number is calculated. When the basic reproduction number is less than one, the disease-free equilibrium is locally stable.
    explanation: The abstract discusses the calculation of the basic reproduction number (R0) for a cholera model but does not mention specific values or the exact factors listed.
  - reference: PMID:32663235
    supports: PARTIAL
    snippet: &#39;The overall R0 across departments was estimated at 2.1 (95% CI: 0.8, 7.3)&#39;
    explanation: The abstract provides an estimated R0 value for cholera in Peru, mentioning spatial variability and correlation with geographic factors but not detailing all the factors listed in the statement.
  - reference: PMID:32678037
    supports: NO_EVIDENCE
    snippet: &#39;RESULTS: We estimated the exponential growth rate as 0.22 per day (95% CI: 0.20-0.24), and the basic reproduction number, R0, as 2.37 (95% CI: 2.22-2.51) based on the assumption that the exponential growth starting from 1 March 2020&#39;
    explanation: The abstract discusses the R0 for COVID-19, not cholera.
  - reference: PMID:18091420
    supports: NO_EVIDENCE
    snippet: The incidence of cholera in Bangladesh shows clear seasonality, suggesting that weather factors could play a role in its epidemiology.
    explanation: The abstract discusses the effect of rainfall on cholera incidence but does not provide specific R0 values or detail the factors affecting R0.
- name: Effective Reproduction Number (R or Rt)
  description: The average number of secondary cases per infectious case in a population made up of both susceptible and non-susceptible individuals.
  minimum_value: 0.5
  maximum_value: 8
  notes: Changes over time as control measures are implemented and population immunity increases. Rt &lt; 1 indicates declining epidemic.
  factors:
  - Proportion of susceptible individuals
  - Control measures (e.g., improved sanitation, vaccination)
  - Changes in behavior (e.g., increased hygiene practices)
  evidence:
  - reference: PMID:34550374
    supports: NO_EVIDENCE
    snippet: Cholera outbreaks currently account for 1.3 to 4.0 million cases and cause between 21 000 and 143 000 deaths worldwide. Cholera is preventable by proper sanitization and immunization; however, in many developing nations such as India, cholera disease is endemic.
    explanation: The provided literature discusses cholera outbreaks and prevention but does not provide specific information on the effective reproduction number (R or Rt) for cholera.
  - reference: PMID:24245619
    supports: NO_EVIDENCE
    snippet: A new model for the dynamics of cholera is formulated that incorporates both the infection age of infectious individuals and biological age of pathogen in the environment. The basic reproduction number is defined and proved to be a sharp threshold determining whether or not cholera dies out.
    explanation: While the literature defines the basic reproduction number for cholera, it does not provide specific values for the effective reproduction number (R or Rt) or discuss the factors affecting it.
- name: Serial Interval
  description: The time between the onset of symptoms in a primary case and the onset of symptoms in secondary cases.
  unit: days
  minimum_value: 1
  maximum_value: 10
  mean_range: 3-5
  notes: Important for estimating R and modeling the speed of epidemic spread.
  evidence:
  - reference: PMID:30594260
    supports: NO_EVIDENCE
    snippet: To evaluate the change in reported cholera cases following Hurricane Matthew on reported cholera cases, we used interrupted time series regression models of daily reported cholera cases, controlling for the impact of both rainfall, following a 4-week lag, and seasonality, from 2013 through 2016.
    explanation: The reference discusses the change in reported cholera cases following a natural disaster, but does not provide information about the serial interval of cholera.
  - reference: PMID:36654005
    supports: NO_EVIDENCE
    snippet: In this paper, we consider an age-structured cholera model with saturation incidence, vaccination age of vaccinated individuals, infection age of infected individuals, and biological age of pathogens.
    explanation: Although the reference discusses cholera transmission models, it does not provide data on the serial interval of cholera.
  - reference: PMID:32054785
    supports: NO_EVIDENCE
    snippet: We develop a simulation model of the spatial spread of an epidemic in order to examine the impact of a pathogen&#39;s incubation period on the dynamics of spread and the predictability of outbreaks.
    explanation: This reference addresses the impact of incubation periods on the spread and predictability of outbreaks, but does not detail the serial interval for cholera.
  - reference: PMID:30114215
    supports: NO_EVIDENCE
    snippet: We use approximate Bayesian computation to estimate parameters in a climate-driven stochastic epidemic model, including the basic reproduction number R0.
    explanation: The study provides data on influenza epidemiology, not cholera, and does not mention serial interval.
  - reference: PMID:21415490
    supports: NO_EVIDENCE
    snippet: The enormity of human sufferings led clinicians and scientists to carry out extensive research on cholera and Vibrio cholerae (the causative bacterium of the disease), leading to major discoveries.
    explanation: Although this refers to cholera research, it does not provide specific information about the serial interval of cholera.
  - reference: PMID:34995131
    supports: NO_EVIDENCE
    snippet: &#39;We review methods, applications, challenges and opportunities for real-time infectious disease modeling during public health emergencies, with examples drawn from the two deadliest pandemics in recent history: HIV/AIDS and coronavirus disease 2019 (COVID-19).&#39;
    explanation: This reference discusses real-time disease modeling with a focus on HIV/AIDS and COVID-19, not cholera.
- name: Generation Time
  description: The time between the infection of a primary case and the infection of secondary cases.
  unit: days
  minimum_value: 1
  maximum_value: 9
  mean_range: 2-4
  notes: Often shorter than the serial interval due to potential pre-symptomatic transmission.
  evidence:
  - reference: PMID:21704640
    supports: NO_EVIDENCE
    snippet: We have quantified a joint distribution of generation time and incubation period by a novel estimation method for household data with two susceptible individuals, consisting of time intervals between disease onsets of two measles cases.
    explanation: The literature provides information about the generation time and incubation period of measles, not cholera.
- name: Case Fatality Rate (CFR), untreated
  unit: percentage
  minimum_value: 25
  maximum_value: 50
  notes: Varies significantly based on access to treatment and quality of care.
  evidence:
  - reference: PMID:9260522
    supports: PARTIAL
    snippet: The CFR in Africa reached 5.7%, representing the highest figure in all the regions
    explanation: This shows variability in CFR. Although some regions have higher CFRs, they do not reach the minimum value of 25% stated in the claim. This indicates that CFRs can be high but do not necessarily reach the extreme values suggested here.
- name: Case Fatality Rate (CFR), treated
  unit: percentage
  maximum_value: 1
  notes: Varies significantly based on access to treatment and quality of care.
  evidence:
  - reference: PMID:24101648
    supports: PARTIAL
    snippet: District CFRs ranged from 0% to 14.3%.
    explanation: The literature indicates a wide range of CFRs, which aligns with the notion that it varies significantly based on access to treatment and quality of care, but it does not provide specific data about the maximum value of 1% in treated cases.
  - reference: PMID:30184102
    supports: PARTIAL
    snippet: Cholera impacts communities already burdened by conflict, lack of infrastructure, poor health systems, and malnutrition.
    explanation: This implies variability in CFR based on care access but does not provide explicit maximum CFR values for treated cases.
- name: Infectivity Period
  unit: days
  minimum_value: 1
  maximum_value: 10
  notes: Can be longer in asymptomatic carriers. Important for determining isolation periods and contact tracing windows.
  evidence:
  - reference: PMID:25114012
    supports: PARTIAL
    snippet: The average length of bacterial shedding was 2.0 days (95% confidence interval 1.7-2.4). However, 16 (5%) of 294 contacts shed V. cholerae for &gt;/= 4 days.
    explanation: The literature indicates an average infectivity period of around 2 days, with some individuals shedding bacteria for 4 or more days, thus partially aligning with the statement&#39;s range of 1-10 days.
  - reference: PMID:23201968
    supports: PARTIAL
    snippet: We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6)... 95% by 4.4 days (95% CI 3.9-5.0) after infection.
    explanation: This estimate focuses on the incubation period rather than the entire infectivity period, providing partial support for the statement’s range of 1-10 days.
  - reference: PMID:37961651
    supports: PARTIAL
    snippet: Most infections with pandemic Vibrio cholerae are thought to result in subclinical disease and are not captured by surveillance. Previous estimates of the ratio of infections to clinical cases have varied widely (2 to 100).
    explanation: The infectivity period is implied to have variability, including asymptomatic carriers, but specific durations are not explicitly detailed, offering partial support.
- name: Peak Infectivity post symptom onset
  unit: days
  minimum_value: 3
  maximum_value: 5
  evidence:
  - reference: PMID:23201968
    supports: SUPPORT
    snippet: We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.
    explanation: The data indicates that the peak infectivity of cholera post symptom onset occurs between 3 and 5 days.
- name: Incubation Period
  unit: days
  minimum_value: 0
  maximum_value: 5
  mean_range: 2-3
  notes: Affects the timing of symptom onset and the implementation of control measures.
  evidence:
  - reference: PMID:23201968
    supports: PARTIAL
    snippet: We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.
    explanation: The statement indicates a mean incubation period range of 2-3 days, whereas the median and the 95th percentile in the literature slightly differ from these ranges. The maximum incubation period provided (5 days) aligns with the literature.
- name: Attack Rate, typical
  description: The proportion of susceptible individuals who become ill during a specified time interval.
  unit: percentage
  minimum_value: 0.1
  maximum_value: 2
  notes: Varies widely depending on environmental conditions and population susceptibility.
  evidence:
  - reference: PMID:36123095
    supports: NO_EVIDENCE
    snippet: The overall AR was 46.5 per 100 000 persons. The North-West region recorded the highest AR with 102 per 100 000.
    explanation: The attack rate given in the reference is not directly expressing the percentage range specified in the statement (0.1 to 2 percent).
- name: Attack Rate, severe
  description: The proportion of susceptible individuals who become ill during a specified time interval.
  unit: percentage
  minimum_value: 5
  maximum_value: 10
  notes: Varies widely depending on environmental conditions and population susceptibility.
  evidence:
  - reference: PMID:35605949
    supports: NO_EVIDENCE
    snippet: The outbreak periods accounted for 1.8 billion person-months (2% of the total during this period) from January 2010 to January 2020. Among 692 outbreaks reported from second-level administrative units (e.g., districts), the median attack rate was 0.8 per 1000 people (interquartile range (IQR), 0.3-2.4 per 1000), the median epidemic duration was 13 weeks (IQR, 8-19), and the median early outbreak reproductive number was 1.8 (range, 1.1-3.5). Larger attack rates were associated with longer times to outbreak peak, longer epidemic durations, and lower case fatality risks.
    explanation: The literature provides the median attack rate in per 1000 people, not percentages, and does not specify a range of 5%-10%. It mentions attack rates in terms of per thousand people which is not directly related to the percentages specified in the statement.
  - reference: PMID:37961651
    supports: NO_EVIDENCE
    snippet: Understanding cholera epidemiology and immunity relies on the ability to translate between numbers of clinical cases and the underlying number of infections in the population. We estimated the infection incidence during the first months of an outbreak in a cholera-naive population using a Bayesian vibriocidal antibody titer decay model combining measurements from a representative serosurvey and clinical surveillance data.
    explanation: This reference discusses the ratio of infections to clinical cases rather than specifying the attack rate range in percentages as stated in the claim.
- name: Asymptomatic Ratio
  description: The proportion of infected individuals who do not display symptoms.
  unit: percentage
  minimum_value: 10
  maximum_value: 80
  notes: Highly variable and challenging to measure accurately. Critical for understanding true disease spread and implementing control measures.
  evidence:
  - reference: PMID:18704085
    supports: SUPPORT
    snippet: Here we show that a model incorporating high asymptomatic ratio ... We find that the asymptomatic ratio in cholera is far higher than had been previously supposed.
    explanation: The study highlights that the asymptomatic ratio in cholera is much higher than previous estimates and provides evidence that it is critical for understanding cholera transmission dynamics.
  - reference: PMID:32529415
    supports: SUPPORT
    snippet: They indicate the existence of bacteria and asymptomatic individuals in the population of Senegal at any single time.
    explanation: The study suggests the presence of a significant asymptomatic population that is crucial in the spread and endemicity of cholera.
  - reference: PMID:2341728
    supports: NO_EVIDENCE
    snippet: A total of 74 inmates (18 symptomatic and 56 asymptomatic) were infected.
    explanation: Although this study documents asymptomatic cases, it does not provide specific support for the general asymptomatic ratio range (10-80%).
  - reference: PMID:35259956
    supports: PARTIAL
    snippet: Prognostic metrics of unfolding outbreaks are of particular importance.
    explanation: This study touches on the role of prognostic indices in understanding outbreaks but does not directly address the asymptomatic ratio range specified (10-80%).
modeling_considerations:
- name: Environmental Dynamics
  description: Include water contamination levels and seasonal variations
  evidence:
  - reference: PMID:11880057
    supports: SUPPORT
    snippet: Cholera dynamics in endemic regions display regular seasonal cycles and pronounced interannual variability.
    explanation: The reference discusses how cholera dynamics are influenced by seasonal cycles and environmental factors, supporting the inclusion of water contamination levels and seasonal variations in modeling considerations.
  - reference: PMID:33333823
    supports: SUPPORT
    snippet: Previous studies have established strong relationships between essential climate variables and the coastal distribution and seasonal dynamics of the bacteria Vibrio cholerae.
    explanation: This study emphasizes the importance of environmental factors and seasonal dynamics for understanding cholera risk, aligning with the modeling considerations mentioned in the statement.
  - reference: PMID:28253325
    supports: PARTIAL
    snippet: A substantial body of work supports a teleconnection between the El Niño-Southern Oscillation (ENSO) and cholera incidence in Bangladesh
    explanation: While this reference emphasizes seasonal variations related to climate phenomena like ENSO, it lacks direct mention of water contamination levels, hence it is partial support.
  - reference: PMID:30861666
    supports: SUPPORT
    snippet: Cholera is an acute intestinal illness caused by infection with the bacterium Vibrio cholerae. The dynamics of the disease transmission are governed by human-human, environment-human, and within-human sub-dynamics.
    explanation: This paper supports the need to consider environmental dynamics, including possible factors like water contamination, in cholera modeling.
- name: Population Mobility
  description: Consider movement patterns that can spread the disease
  evidence:
  - reference: PMID:22355581
    supports: SUPPORT
    snippet: We find that prevalence-based travel limitations do not alter the epidemic invasion threshold. Strikingly, we observe in both synthetic and data-driven numerical simulations that when travelers decide to avoid locations with high levels of prevalence, this self-initiated behavioral change may enhance disease spreading.
    explanation: The study analyzes how travel behavior and movement patterns can influence the spread of diseases, supporting the statement that population mobility should be considered in cholera modeling.
  - reference: PMID:12220086
    supports: PARTIAL
    snippet: The high-risk areas of the dominant cholera agents are relatively stable over time. However, from 1983-1987 El Tor cholera, which was not the dominant agent during that period, was not associated with high-risk areas, suggesting that the El Tor habitat may have changed over time.
    explanation: While the study focuses on environmental risk factors and high-risk areas, it indirectly implies the importance of understanding mobility and environmental aspects, partially supporting the statement.
  - reference: PMID:32529415
    supports: NO_EVIDENCE
    snippet: Our interest lies in estimating such states and the parameters catalyzing the spread.
    explanation: The study primarily focuses on modeling inaccessible states and parameters of cholera spread rather than movement patterns or population mobility.
  - reference: PMID:36573576
    supports: SUPPORT
    snippet: This study demonstrates the use of epidemiological modeling to understand the dynamics of cholera transmission to inform emergency planning and military preparedness in areas with highly communicable diseases.
    explanation: The study emphasizes the role of modeling the spread of cholera in specific settings, highlighting the need to account for local population movements.
  - reference: PMID:31345641
    supports: NO_EVIDENCE
    snippet: Whole genome sequence analysis has revealed the phylogenetic structure of Vibrio cholerae and has shown that the current seventh pandemic is highly clonal, emerging from a single source.
    explanation: The study focuses on the genetic aspects and phylogenetic structure of Vibrio cholerae, not directly addressing movement patterns.
  - reference: PMID:35381862
    supports: SUPPORT
    snippet: Cholera is a water- and food-borne infectious disease caused by V. cholerae. To investigate multiple effects of human behavior change, seasonality and spatial heterogeneity on cholera spread, we propose a reaction-advection-diffusion model that incorporates human hosts and aquatic reservoir of V. cholerae.
    explanation: This study supports the statement by proposing a model that includes human behavior and spatial heterogeneity, directly considering movement and its effect on cholera spread.
  - reference: PMID:31226251
    supports: PARTIAL
    snippet: Population displacement and other forced movement patterns following natural disasters, armed conflicts or due to socioeconomic reasons contribute to the global emergence of Aedes-borne viral disease epidemics.
    explanation: While the focus is on Aedes-borne diseases, the study points out the significant impact of population displacement on disease spread, partially relevant to cholera modeling considerations.
  - reference: PMID:34550373
    supports: PARTIAL
    snippet: Mathematical modeling can be used to project the impact of mass vaccination on cholera transmission. Here, we discuss 2 examples for which indirect protection from mass vaccination needs to be considered.
    explanation: The study discusses cholera transmission models and factors like vaccination but does not specifically emphasize population mobility; however, it partially aligns with overall modeling considerations.
  - reference: PMID:15226199
    supports: SUPPORT
    snippet: The collapse of geographical space over the last 200 years has had profound effects on the circulation of human populations and on the transfer of infectious diseases.
    explanation: The study discusses the significant impact of population movement and travel on the spread of infectious diseases, supporting the need to consider such factors in cholera modeling.
- name: Intervention Impacts
  description: Model effects of vaccination, improved sanitation, and treatment access
  evidence:
  - reference: PMID:21540075
    supports: SUPPORT
    snippet: We formulate a mathematical model that captures some essential dynamics of cholera transmission to study the impact of public health educational campaigns, vaccination and treatment as control strategies in curtailing the disease.
    explanation: This paper explicitly discusses a mathematical model analyzing the impacts of vaccination, public health education, and treatment on cholera transmission.
- name: Asymptomatic Carriers
  description: Account for their role in disease transmission
  evidence:
  - reference: PMID:5300876
    supports: SUPPORT
    snippet: The strains isolated from carriers were identical in all respects, including virulence in infant rabbits, with strains isolated from patients.
    explanation: This study shows that carriers, including asymptomatic ones, have strains identical to those from symptomatic patients, indicating their role in disease transmission.
  - reference: PMID:32529415
    supports: SUPPORT
    snippet: The ever existence of cholera pathogen explains the endemicity of Cholera in Senegal and other sub-Saharan-African countries owing to role played by the asymptomatic individual in the bacteria density.
    explanation: The study explicitly mentions the role of asymptomatic individuals in maintaining the bacteria density, which contributes to the transmission of cholera.
  - reference: PMID:21675806
    supports: SUPPORT
    snippet: An S-Ic-I-R epidemic model is investigated for infectious diseases that can be transmitted through carriers, infected individuals who are contagious but do not show any disease symptoms.
    explanation: The study discusses the transmission dynamics of infectious diseases through carriers, including those who are asymptomatic, which supports the role of asymptomatic carriers in disease transmission.
- name: Super-spreading Events
  description: Consider potential for rapid spread in gatherings or contaminated water sources
  evidence:
  - reference: PMID:25140600
    supports: SUPPORT
    snippet: A mathematical model is formulated for the transmission and spread of cholera in a heterogeneous host population that consists of several patches of homogeneous host populations sharing a common water source.
    explanation: The reference discusses modeling considerations for cholera transmission, specifically noting the potential for spread through common water sources.
  - reference: PMID:19171080
    supports: SUPPORT
    snippet: We identified that consumption of milk products prepared in the household of the index case...and drinking well water in the second village were associated with the illness.
    explanation: The study highlights how mishandling of food and contamination of water sources can lead to cholera outbreaks, aligning with considerations for spread in gatherings and contaminated water sources.
- name: Stochastic vs Deterministic Models
  description: Choose appropriate modeling approach based on population size and heterogeneity
  evidence:
  - reference: PMID:10652843
    supports: SUPPORT
    snippet: The dynamics of deterministic and stochastic discrete-time epidemic models are analyzed and compared... The discrete-time stochastic models are Markov chains, approximations to the continuous-time models. Models of SIS and SIR type with constant population size and general force of infection are analyzed, then a more general SIS model with variable population size is analyzed.
    explanation: This paper discusses the considerations for choosing between deterministic and stochastic models based on population characteristics, supporting the statement.
  - reference: PMID:15015922
    supports: SUPPORT
    snippet: Understanding what determines patterns of infection spread in populations is important for controlling infection transmission... This involves changing model forms from deterministic to stochastic and from compartmental to network, as well as adding realistic detail and changing parameter values.
    explanation: The excerpt highlights the importance of selecting appropriate modeling approaches, including deterministic and stochastic models, based on population details, supporting the statement.
  - reference: PMID:33830353
    supports: SUPPORT
    snippet: We apply a time-nonhomogeneous stochastic process for a cholera epidemic with seasonal periodicity and a multitype branching process approximation to obtain an analytical estimate for the probability of an outbreak... At the end, the developed theoretical results are extended to more general models of infectious diseases.
    explanation: The study applies stochastic modeling to cholera epidemics and discusses extending these results to other infectious diseases, thus supporting the statement.
- name: Spatial Considerations
  description: Incorporate geographical factors affecting disease spread and control measures
  evidence:
  - reference: PMID:22781421
    supports: SUPPORT
    snippet: All the data were imported to system database to show the incidence of vibrio cholerae in different provinces, regions and counties to support the spatial analysis through the spatial analysis of GIS.
    explanation: The reference discusses the importance of geographical information systems (GIS) to show the incidence of cholera in different locations, which supports the statement on incorporating geographical considerations.
  - reference: PMID:28483382
    supports: SUPPORT
    snippet: The inclusion of spatial information in models of disease transmission can aid in emergency management and the assessment of alternative interventions.
    explanation: This reference emphasizes the inclusion of spatial data in models of disease transmission, supporting the importance of geographical factors in modeling cholera.
  - reference: PMID:33705444
    supports: SUPPORT
    snippet: We applied a set of spatial statistical analyses to investigate the spatial heterogeneity and the factors that influence the cholera epidemic in the Jiangnan area.
    explanation: The study investigates the spatial distribution of cholera and the influence of natural environmental factors, supporting the use of geographical considerations in cholera modeling.
  - reference: PMID:24047241
    supports: SUPPORT
    snippet: Problems with unsafe water, sanitation and dirty environments were the most common perceived causes across settings.
    explanation: Although not exclusively focused on modeling, the reference discusses geographical and environmental factors affecting cholera, which are integral to spatial considerations.
- name: Vaccination Dynamics
  description: Model the impact of vaccination campaigns, including coverage rates and vaccine efficacy
  evidence:
  - reference: PMID:32987576
    supports: SUPPORT
    snippet: We consider an optimal control problem of cholera transmission with vaccination, quarantine, treatment and sanitation control strategies, and use Pontryagin&#39;s minimum principle to determine the optimal control level.
    explanation: The study includes modeling the impact of vaccination campaigns on cholera transmission, examining coverage rates and vaccine efficacy.
  - reference: PMID:35123444
    supports: SUPPORT
    snippet: The aim of this project was to assess the feasibility and effect of using recommendations of a community-based immunization and communication coverage survey conducted after the first round of an OCV campaign on the coverage of the second-round of the campaign.
    explanation: The study discusses the impact of vaccination campaigns on cholera, focusing on coverage rates and resultant improvements in immunization effectiveness.
  - reference: PMID:24845800
    supports: SUPPORT
    snippet: Application of the IPW estimators to the cholera vaccine trial indicates the presence of interference.
    explanation: The study analyzes indirect effects and interference in cholera vaccination campaigns, providing insights into the impact of coverage rates and vaccine efficacy.
  - reference: PMID:28748506
    supports: SUPPORT
    snippet: We propose two differential equation-based models to investigate the impact of awareness programs on cholera dynamics. The first model represents the disease transmission rates as decreasing functions of the number of awareness programs, whereas the second model divides the susceptible individuals into two distinct classes depending on their awareness/unawareness of the risk of infection.
    explanation: This research includes modeling approaches that consider the impact of vaccination schemes and coverage rates, indirectly touching upon vaccination dynamics.
progression:
- phase: Incubation
  duration: 2 hours to 5 days
  notes: Period between infection and onset of symptoms. Individuals are typically not infectious during this phase.
  evidence:
  - reference: PMID:23201968
    supports: PARTIAL
    snippet: We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.
    explanation: The literature describes an incubation period median of 1.4 days and a window from 0.5 days to 4.4 days for symptom onset, which is consistent with a portion of the stated range but does not completely align.
- phase: Prodromal
  duration: Hours
  notes: Early symptoms may include mild diarrhea, abdominal discomfort, and nausea. Often overlooked or misdiagnosed.
  evidence:
  - reference: PMID:1465231
    supports: NO_EVIDENCE
    snippet: Cholera is a diarrheal disease that results from colonization of the small intestine by the Vibrio cholerae organism. The disease is spread primarily by means of fecal contamination of drinking water and may begin with the sudden onset of profuse, watery diarrhea. Vomiting, rapid dehydration, acidosis, muscular cramps and circulatory collapse are other prominent features of severe cholera.
    explanation: The reference discusses the symptoms and features of cholera but does not provide information specific to the progression phase or the duration of the prodromal phase.
  - reference: PMID:23201968
    supports: NO_EVIDENCE
    snippet: We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.
    explanation: This reference provides data on the incubation period of cholera but does not detail the duration of the prodromal phase or early symptoms specific to hours.
  - reference: PMID:38702080
    supports: NO_EVIDENCE
    snippet: The study found results consistent with previous AWD outbreaks in developing countries like Yemen, Nigeria and Lebanon.
    explanation: The reference is focused on acute watery diarrhea during cholera outbreaks but does not offer details on the prodromal phase duration or specific early symptoms.
  - reference: PMID:37580033
    supports: NO_EVIDENCE
    snippet: From May 4, 2014 through November 30, 2021, we enrolled 51,414 suspected cases from our sentinel surveillance sites.
    explanation: The study is about national cholera surveillance and does not address the specific progression or the prodromal phase duration in hours.
  - reference: PMID:18704085
    supports: NO_EVIDENCE
    snippet: This is true for cholera, a pandemic bacterial disease, where estimates of the ratio of asymptomatic to symptomatic infections have ranged from 3 to 100 (refs 1-5).
    explanation: This study discusses asymptomatic infections and their implications but does not provide detailed information on early symptoms duration in hours.
  - reference: PMID:29165706
    supports: NO_EVIDENCE
    snippet: We investigated singular Danish cholera epidemics (in 1853) to elucidate epidemiological parameters and modes of spread.
    explanation: The reference concerns historical cholera epidemics and their transmission but does not address the duration of the prodromal phase or early symptoms.
  - reference: PMID:21150867
    supports: NO_EVIDENCE
    snippet: As of December 3, MSPP reported 91,770 cases of cholera from all 10 departments and the capital city of Port-au-Prince.
    explanation: This study details the cholera outbreak in Haiti but does not provide specific information on the early symptoms duration in hours.
  - reference: PMID:8548982
    supports: NO_EVIDENCE
    snippet: The clinical manifestations of cholera and the pathophysiology of the toxin-induced diarrhea are reviewed.
    explanation: This review on cholera&#39;s clinical manifestations does not offer specifics on the duration of the prodromal phase or early symptoms in hours.
  - reference: PMID:23622872
    supports: NO_EVIDENCE
    snippet: We identified 281 Vibrio cholerae non-O1, non-O139 strains from patients with diarrhea in Kolkata, India. Cholera-like diarrhea was the major symptom (66.0%); some patients (20.3%) had severe dehydration.
    explanation: The focus is on non-O1, non-O139 Vibrio cholerae strains and does not provide information on the prodromal phase duration or early symptoms in hours.
- phase: Acute
  duration: Hours to Days
  notes: Rapid onset of severe symptoms, can be life-threatening if not treated promptly. Peak infectiousness.
  evidence:
  - reference: PMID:23201968
    supports: SUPPORT
    snippet: We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.
    explanation: This reference supports the rapid progression of cholera, stating that symptoms can develop within half a day to around 4-5 days after infection.
- phase: Early Acute
  duration: First 24-48 hours
  notes: Rapid onset of profuse, watery diarrhea and vomiting. Highest risk of severe dehydration.
  evidence:
  - reference: PMID:37769103
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The abstract does not provide specific information about the progression of cholera within the first 24-48 hours.
  - reference: PMID:8548982
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The abstract covers the epidemiology and general clinical manifestations but does not detail the progression specific to the first 24–48 hours.
  - reference: PMID:31668817
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The abstract reviews case management of cholera but does not provide information specifically regarding the initial 24-48 hours.
  - reference: PMID:20135270
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The abstract estimates the prevalence of cholera in pediatric patients with acute dehydrating diarrhea but does not specify the time frame within the first 24-48 hours.
- phase: Late Acute
  duration: 3-5 days
  notes: Continued symptoms but may begin to improve with proper treatment.
  evidence:
  - reference: PMID:23201968
    supports: NO_EVIDENCE
    snippet: We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.
    explanation: While this paper provides information on the incubation period of cholera rather than the duration of symptoms, it indirectly suggests that the symptom onset and duration can vary significantly.
  - reference: PMID:31668817
    supports: NO_EVIDENCE
    snippet: Cholera can be effectively managed in the majority of cases with oral rehydration solution alone. Up to one third of patients present with severe dehydration, which can be diagnosed clinically, and will require rapid intravenous rehydration...
    explanation: This reference focuses more on the treatment and management of cholera rather than the progression and duration of symptoms.
- phase: Recovery
  duration: Days to Weeks
  notes: Symptoms resolve, but individuals may still shed bacteria in stool for 1-2 weeks.
  evidence:
  - reference: PMID:23201968
    supports: PARTIAL
    snippet: Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.
    explanation: The reference provides information on the incubation period but not on the overall progression of the disease or the recovery phase.
  - reference: PMID:10414380
    supports: PARTIAL
    snippet: Nine (69.2%) of the convalescents had positive faecal cultures for periods ranging from two weeks to more than seven months.
    explanation: This literature supports that bacteria can be shed in stool during the convalescent period but does not provide a comprehensive view of the full disease progression or typical duration of symptoms.
- phase: Asymptomatic Carriage
  duration: Days to Months
  notes: Some individuals can carry and shed the bacteria without showing symptoms. Important for disease transmission modeling.
  evidence:
  - reference: PMID:5300876
    supports: SUPPORT
    snippet: The duration of the carrier state among 19 household carriers isolated for examination varied from 5 to 19 days.
    explanation: This literature provides data on the duration of the carrier state, indicating that some individuals can carry and shed the bacteria for several days, which supports the statement regarding the duration of asymptomatic carriage.
  - reference: PMID:8373550
    supports: SUPPORT
    snippet: There are also cases of cholera where victims do not show any symptoms of it, that is asymptomatic carriers.
    explanation: The statement about asymptomatic carriage is supported, as the literature confirms the existence of asymptomatic carriers who can harbor the bacteria for varying periods.
  - reference: PMID:32529415
    supports: PARTIAL
    snippet: They indicate the existence of bacteria and asymptomatic individuals in the population of Senegal at any single time for the duration of collection of the data.
    explanation: The statement is partially supported as the literature indicates the presence of asymptomatic carriers in the population, although it does not specify the exact duration of carriage.
  - reference: PMID:28483382
    supports: NO_EVIDENCE
    snippet: Information on human settlements and host mobility on waterways along which pathogens and hosts disperse, and relevant hydroclimatological processes, can be acquired remotely and included in spatially explicit mathematical models of disease transmission.
    explanation: This study focuses on drivers of cholera transmission using spatially explicit models and does not provide information on the duration of asymptomatic carriage.
  - reference: PMID:34670655
    supports: NO_EVIDENCE
    snippet: This study describes the apparent discontinuation of cholera transmission in Haiti since February 2019.
    explanation: This study discusses cholera transmission cessation in Haiti and does not address the duration of asymptomatic carriage.
  - reference: PMID:23201968
    supports: NO_EVIDENCE
    snippet: The incubation period did not differ by a clinically significant margin between strains (except O1 El Tor Ogawa).
    explanation: This review focuses on the incubation period of cholera and does not discuss the duration of asymptomatic carriage.
  - reference: PMID:22461716
    supports: NO_EVIDENCE
    snippet: About 1.4 billion people are at risk for cholera in endemic countries.
    explanation: This study estimates the global burden of cholera and does not provide information on the duration of asymptomatic carriage.
pathophysiology:
- name: Cholera Toxin Binding and Uptake
  description: Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.
  cell_types:
  - preferred_term: intestinal epithelial cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  biological_processes:
  - preferred_term: endocytosis
    term:
      id: GO:0006897
      label: endocytosis
  - preferred_term: retrograde vesicle-mediated transport
    term:
      id: GO:0006890
      label: retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
  downstream:
  - target: ERAD-mediated CTA1 Translocation
  notes: CTB recognizes both GM1 ganglioside and fucosylated glycoproteins, enabling GM1-independent intoxication
- name: ERAD-mediated CTA1 Translocation
  description: The A1 enzymatic subunit of cholera toxin is unfolded by protein disulfide isomerase in the ER and hijacks the ER-associated degradation (ERAD) machinery to retro-translocate into the cytosol, where it refolds to become enzymatically active.
  cell_types:
  - preferred_term: intestinal epithelial cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  biological_processes:
  - preferred_term: ERAD pathway
    term:
      id: GO:0030433
      label: ubiquitin-dependent ERAD pathway
  downstream:
  - target: Gsα ADP-Ribosylation
  notes: CTA1 exploits the Sec61/Derlin/Hrd1 retro-translocation machinery to escape the ER
- name: Gsα ADP-Ribosylation
  description: Cytosolic CTA1 catalyzes ADP-ribosylation of the Gsα subunit (GNAS) using NAD+ as substrate, locking adenylyl cyclase in a constitutively active state.
  cell_types:
  - preferred_term: intestinal epithelial cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  biological_processes:
  - preferred_term: adenylate cyclase-activating G protein-coupled receptor signaling pathway
    term:
      id: GO:0007189
      label: adenylate cyclase-activating G protein-coupled receptor signaling pathway
  downstream:
  - target: Increased cAMP
- name: Cholera Toxin
  description: Vibrio cholerae produces a toxin that activates adenylate cyclase in intestinal epithelial cells, leading to increased cyclic AMP (cAMP) levels.
  cell_types:
  - preferred_term: intestinal epithelial cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  downstream:
  - target: Increased cAMP
  evidence:
  - reference: PMID:8783505
    supports: SUPPORT
    snippet: Vibrio cholerae produce a variety of extracellular products that have deleterious effects on eukaryotic cells... CT acts by activation of adenylate cyclase-cAMP system located at the basolateral membrane of intestinal epithelial cells.
    explanation: The statement is supported by the information that cholera toxin (CT) from Vibrio cholerae activates the adenylate cyclase-cAMP system in intestinal epithelial cells.
  - reference: PMID:30624615
    supports: SUPPORT
    snippet: Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR).
    explanation: The statement is supported as it describes CT inducing diarrhea through cAMP-mediated mechanisms.
  - reference: PMID:4364505
    supports: SUPPORT
    snippet: Comparable results were also obtained when cholera toxin was used. The degree of enzyme stimulation was proportional to the concentration of enterotoxin.
    explanation: This further confirms that cholera toxin stimulates adenylate cyclase activity in cells.
  - reference: PMID:8817767
    supports: SUPPORT
    snippet: V cholerae, the representative noninvasive pathogen, has fimbrial adhesins that mediate attachment and colonization... organisms secrete cholera toxin (CT), a potent enterotoxin that induces a voluminous diarrhea via adenylate cyclase-dependent chloride secretion.
    explanation: This literature confirms that cholera toxin induces diarrhea by acting on the adenylate cyclase system in the intestinal epithelial cells, resulting in elevated cAMP levels.
- name: Increased cAMP
  description: Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes.
  cell_types:
  - preferred_term: intestinal epithelial cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  biological_processes:
  - preferred_term: cAMP-mediated signaling
    term:
      id: GO:0019933
      label: cAMP-mediated signaling
  - preferred_term: chloride transmembrane transport
    term:
      id: GO:1902476
      label: chloride transmembrane transport
  downstream:
  - target: Profuse Watery Diarrhea
  evidence:
  - reference: PMID:23651092
    supports: SUPPORT
    snippet: Increased intracellular cAMP in human intestinal epithelial cells accounts for pathogenesis of profuse diarrhea and severe fluid loss in cholera
    explanation: This reference directly supports the statement by confirming that elevated cAMP levels in intestinal epithelial cells lead to the secretion of fluid, resulting in profuse diarrhea, which aligns with the described pathophysiology.
  - reference: PMID:30624615
    supports: SUPPORT
    snippet: Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR).
    explanation: This reference supports the statement by explaining that CT-induced diarrhea involves cAMP-mediated chloride secretion, leading to diarrhea.
  - reference: PMID:80378
    supports: PARTIAL
    snippet: Cholera toxin causes net secretion of fluid into the small intestine of weanling pigs, and secretory rates are dependent on the dose of the toxin placed in intestinal loops.
    explanation: While this study supports that cholera toxin leads to fluid secretion, it notes that net fluid fluxes did not always correlate with total mucosal cAMP concentrations in pigs. Therefore, it provides partial evidence for the described pathophysiology.
- name: Profuse Watery Diarrhea
  description: Rapid loss of fluids and electrolytes through diarrhea, which can lead to severe dehydration and hypovolemic shock.
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  evidence:
  - reference: PMID:14738797
    supports: SUPPORT
    snippet: Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock.
    explanation: The statement describes the loss of large volumes of fluids and electrolytes through diarrhea, leading to severe dehydration and hypovolemic shock, which aligns with the literature.
  - reference: PMID:15367740
    supports: SUPPORT
    snippet: A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal.
    explanation: The literature describes large fluid losses and severe dehydration due to cholera, supporting the statement&#39;s explanation of pathophysiology.
  - reference: PMID:28448489
    supports: SUPPORT
    snippet: To take advantage of emerging opportunities to reduce morbidity and mortality from diarrheal disease, we need to better understand the determinants of life-threatening severe dehydration (SD) in resource-poor settings.
    explanation: The text mentions severe dehydration as a key issue in the pathophysiology of cholera.
  - reference: PMID:34523840
    supports: SUPPORT
    snippet: A 28-year-old female presented with severe dehydration due to acute diarrhea and vomiting... which is typical for cholera and can amount to 1000 cc/hour.
    explanation: This literature supports the rapid loss of fluids through profuse watery diarrhea leading to severe dehydration, consistent with the pathophysiology described.
  - reference: PMID:38702080
    supports: SUPPORT
    snippet: The most common complications reported at admission and during hospitalisation included electrolyte imbalance (28.2%), followed by severe dehydration (16.3%).
    explanation: This literature mentions severe dehydration and electrolyte imbalance as common complications, supporting the statement regarding the pathophysiology of cholera.
- name: Colonization and Biofilm Formation
  description: V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission.
  cell_types:
  - preferred_term: intestinal epithelial cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  biological_processes:
  - preferred_term: biofilm formation
    term:
      id: GO:0042710
      label: biofilm formation
  - preferred_term: bacterial adhesion to host
    term:
      id: GO:0044406
      label: adhesion of symbiont to host
  notes: The neuraminidase NanH removes sialic acids to expose GM1 ganglioside receptors for cholera toxin binding
- name: Accessory Toxins and Virulence Factors
  description: V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner.
  cell_types:
  - preferred_term: intestinal epithelial cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  biological_processes:
  - preferred_term: disruption of cells of other organism
    term:
      id: GO:0044364
      label: disruption of cells of other organism
  - preferred_term: tight junction organization
    term:
      id: GO:0120193
      label: tight junction organization
  notes: MARTX also modulates innate immune signaling; HlyA is often associated with outer membrane vesicles (OMVs)
- name: Host Metabolic Reprogramming
  description: Cholera toxin-driven signaling reprograms host epithelial metabolism, leading to release of host-derived nutrients (long-chain fatty acids, lactate, glycerol) into the intestinal lumen that fuel V. cholerae growth and enhance transmission.
  cell_types:
  - preferred_term: intestinal epithelial cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  locations:
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  biological_processes:
  - preferred_term: regulation of lipid metabolic process
    term:
      id: GO:0019216
      label: regulation of lipid metabolic process
  notes: Bile acids and the gut microbiome modulate biofilm formation and virulence gene expression
phenotypes:
- category: Gastrointestinal
  name: Profuse Watery Diarrhea
  frequency: VERY_FREQUENT
  diagnostic: true
  sequelae:
  - target: Severe Dehydration
  - target: Shock
  evidence:
  - reference: PMID:14738797
    supports: SUPPORT
    snippet: Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock.
    explanation: The provided excerpt supports the statement that profuse watery diarrhea is a very frequent diagnostic phenotype of cholera and that it leads to severe dehydration and shock.
  - reference: PMID:34523840
    supports: SUPPORT
    snippet: Her stool was watery, with flecks of mucous, also referred to as &#39;rice-water&#39; stool, which is typical for cholera and can amount to 1000 cc/hour.
    explanation: This case study supports the characterization of profuse watery diarrhea as a very frequent diagnostic phenotype of cholera.
  - reference: PMID:29488455
    supports: SUPPORT
    snippet: Adding dehydration, vomiting, or rice water stools to the case definition could increase the specificity without a substantial decrease in sensitivity.
    explanation: This study supports that rice-water stools (a form of profuse watery diarrhea) are indicative of cholera and frequently used in its diagnosis.
  - reference: PMID:820813
    supports: SUPPORT
    snippet: The severity of diarrhea and nutritional status were measured in a prospective study of 97 patients hospitalized with cholera in Dacca, Bangladesh... The increased stool loss was unrelated to antibiotic usage, to presence of intestinal parasites, or to the refeeding diet given.
    explanation: The study supports that profuse watery diarrhea is a very frequent diagnostic phenotype of cholera.
  - reference: PMID:27412979
    supports: SUPPORT
    snippet: Choleriform diarrhea and vomiting were the main signs, found respectively in 100% and 95% of the women; dehydration was mild for 16%, moderate for 45%, and severe for 39%.
    explanation: This study supports that profuse watery diarrhea (choleriform diarrhea) is a very frequent diagnostic phenotype of cholera.
  - reference: PMID:38702080
    supports: SUPPORT
    snippet: The most common complications reported at admission and during hospitalisation included electrolyte imbalance (28.2%), followed by severe dehydration (16.3%).
    explanation: This study supports that watery diarrhea leading to severe dehydration is a frequent phenotype of cholera.
- category: Systemic
  name: Dehydration
  frequency: VERY_FREQUENT
  diagnostic: true
  sequelae:
  - target: Sunken Eyes
  - target: Low Blood Pressure
  - target: Tachycardia
  evidence:
  - reference: PMID:28448489
    supports: SUPPORT
    snippet: &#39;Vibrio cholerae was the most common pathogen isolated (12,405 patients; 22%), and had the strongest association with SD (AOR 4.77; 95% CI: 4.41-5.51).&#39;
    explanation: The article notes that Vibrio cholerae was the most common pathogen with a strong association with severe dehydration, which aligns with the statement.
  - reference: PMID:15367740
    supports: PARTIAL
    snippet: A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal.
    explanation: The study discusses severe dehydration, but also mentions metabolic and respiratory complications without specifically noting frequency.
  - reference: PMID:33252133
    supports: PARTIAL
    snippet: It was later confirmed that he was suffering from cholera. On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock.
    explanation: This article discusses a specific case of cholera leading to severe dehydration and hypovolemic shock, but does not provide frequency data.
  phenotype_term:
    preferred_term: Dehydration
    term:
      id: HP:0001944
      label: Dehydration
- category: Systemic
  name: Hypovolemic Shock
  frequency: OCCASIONAL
  notes: Caused by severe dehydration due to fluid loss
  evidence:
  - reference: PMID:33252133
    supports: SUPPORT
    snippet: The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement. In the following case... he was suffering from cholera. On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock.
    explanation: This case description demonstrates that hypovolemic shock is an occasional systemic consequence of cholera due to excessive fluid loss.
  - reference: PMID:14738797
    supports: SUPPORT
    snippet: Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock.
    explanation: This abstract highlights that severe dehydration caused by cholera often leads to shock, supporting the claim.
  phenotype_term:
    preferred_term: Hypovolemic Shock
    term:
      id: HP:0031274
      label: Hypovolemic shock
- category: Systemic
  diagnostic: true
  frequency: VERY_FREQUENT
  name: Dehydration
  sequelae:
  - target: Sunken Eyes
  - target: Low Blood Pressure
  - target: Tachycardia
  - target: Acute Kidney Injury
  notes: Can lead to death within hours if untreated
  evidence:
  - reference: PMID:34523840
    supports: SUPPORT
    snippet: A 28-year-old female presented with severe dehydration due to acute diarrhea and vomiting, which she developed after returning from a vacation in Togo
    explanation: This reference supports the statement by describing a case of severe dehydration due to cholera, highlighting its systemic nature and the rapid onset of severe symptoms.
  - reference: PMID:31668817
    supports: SUPPORT
    snippet: Cholera still affects about three million people a year and kills approximately 100,000. Cholera can be effectively managed in the majority of cases with oral rehydration solution alone. Up to one third of patients present with severe dehydration, which can be diagnosed clinically, and will require rapid intravenous rehydration with Ringers Lactate or other appropriate fluid before being managed with oral rehydration solution.
    explanation: This reference supports the statement by noting that severe dehydration is a common and critical condition in cholera patients, which can lead to death if untreated.
  - reference: PMID:33252133
    supports: SUPPORT
    snippet: The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement.
    explanation: This reference supports the systemic impact of cholera, including dehydration, which can lead to severe complications and death.
  phenotype_term:
    preferred_term: Dehydration
    term:
      id: HP:0001944
      label: Dehydration
- category: Systemic
  frequency: OCCASIONAL
  name: Hypovolemic Shock
  notes: Caused by severe dehydration due to fluid loss
  evidence:
  - reference: PMID:14738797
    supports: SUPPORT
    snippet: Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock.
    explanation: The reference states that cholera leads to severe dehydration and shock, which aligns with the statement indicating that cholera can occasionally cause hypovolemic shock due to severe dehydration.
  - reference: PMID:4869291
    supports: SUPPORT
    snippet: Hemodynamic studies on cholera. Effects of hypovolemia and acidosis.
    explanation: The title of the reference suggests that hypovolemia, which can lead to hypovolemic shock, is a significant effect of cholera.
  - reference: PMID:33252133
    supports: SUPPORT
    snippet: The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement.
    explanation: The reference confirms that cholera causes hypovolemia, which can lead to hypovolemic shock, supporting the statement.
  phenotype_term:
    preferred_term: Hypovolemic Shock
    term:
      id: HP:0031274
      label: Hypovolemic shock
- category: Electrolyte/Metabolic
  frequency: FREQUENT
  name: Hypokalemia
  evidence:
  - reference: PMID:5300879
    supports: SUPPORT
    snippet: Hypokalaemic patterns were seen in 40% of the cases in the acute stage (during rehydration). This pattern became more marked after rehydration and disappeared gradually within 3-7 days.
    explanation: The study indicates that hypokalemia is a frequent occurrence in cholera patients, particularly during the acute stage and rehydration process.
  - reference: PMID:33252133
    supports: NO_EVIDENCE
    snippet: On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock.
    explanation: This case report mentions hyperkalemia in a cholera patient, not hypokalemia. Therefore, it does not support the statement about frequent hypokalemia in cholera.
  - reference: PMID:28957470
    supports: PARTIAL
    snippet: Severe cholera is a life-threatening illness of hypovolemic shock and metabolic acidosis due to rapid and profuse diarrheal fluid loss. Emergency life-saving therapy is i.v. saline, optionally supplemented with potassium and alkali to correct the fluid deficit, potassium losses and acidosis.
    explanation: The reference mentions potassium losses as part of the treatment for severe cholera, which indirectly suggests hypokalemia might occur, but it does not provide direct evidence of its frequency.
  phenotype_term:
    preferred_term: Hypokalemia
    term:
      id: HP:0002900
      label: Hypokalemia
- category: Electrolyte/Metabolic
  frequency: FREQUENT
  name: Metabolic Acidosis
  evidence:
  - reference: PMID:15367740
    supports: SUPPORT
    snippet: A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal. A detailed analysis emphasizing principles of physiology and a quantitative approach provided new insights and eventually better definitions of metabolic and respiratory acidosis.
    explanation: The study discusses the presence of metabolic acidosis in a cholera patient, supporting the statement.
  - reference: PMID:33252133
    supports: SUPPORT
    snippet: The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement.
    explanation: Electrolyte derangement in cholera can lead to conditions like metabolic acidosis, supporting the statement.
  - reference: PMID:5697815
    supports: SUPPORT
    snippet: &#39;Oral maintenance of water-electrolyte and acid-base balance in cholera: a preliminary report.&#39;
    explanation: The mention of acid-base balance in cholera suggests a frequent occurrence of metabolic acidosis, supporting the statement.
  phenotype_term:
    preferred_term: Metabolic Acidosis
    term:
      id: HP:0001942
      label: Metabolic acidosis
- category: Musculoskeletal
  frequency: OCCASIONAL
  name: Muscle Cramps
  notes: Due to electrolyte imbalances
  evidence:
  - reference: PMID:33252133
    supports: PARTIAL
    snippet: On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock.
    explanation: The case study mentions muscle cramping as a symptom in a patient with cholera, but does not explicitly link it to electrolyte imbalances.
  - reference: PMID:29857264
    supports: NO_EVIDENCE
    snippet: Literature analysis indicates that neuromuscular hypothesis may prevails over the initial hypothesis of the dehydration as the trigger event of muscle cramps.
    explanation: This review focuses on the neuromuscular hypothesis for muscle cramps and does not provide evidence linking muscle cramps to electrolyte imbalances specifically in cholera.
  - reference: PMID:9694423
    supports: NO_EVIDENCE
    snippet: Cramps occur during or after exercise regardless of whether the exercise is performed in the heat or the cold, or in water.
    explanation: The review discusses muscle cramps in the context of exercise and heat illness, but does not relate it to cholera or electrolyte imbalances.
  phenotype_term:
    preferred_term: Muscle Cramps
    term:
      id: HP:0003394
      label: Muscle spasm
- category: Systemic
  name: Severe Dehydration
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Severe Dehydration
    term:
      id: HP:0001944
      label: Dehydration
- category: Systemic
  name: Shock
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Shock
    term:
      id: HP:0031273
      label: Shock
- category: Systemic
  name: Sunken Eyes
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sunken Eyes
    term:
      id: HP:0000490
      label: Deeply set eye
- category: Cardiovascular
  name: Low Blood Pressure
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Low Blood Pressure
    term:
      id: HP:0002615
      label: Hypotension
- category: Cardiovascular
  name: Tachycardia
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Tachycardia
    term:
      id: HP:0001649
      label: Tachycardia
- category: Renal
  name: Acute Kidney Injury
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Acute Kidney Injury
    term:
      id: HP:0001919
      label: Acute kidney injury
biochemical:
- name: Electrolytes
  presence: Low Sodium, Potassium, and Bicarbonate Levels
  context: Due to excessive loss in diarrhea
  evidence:
  - reference: PMID:28957470
    supports: PARTIAL
    snippet: Emergency life-saving therapy is i.v. saline, optionally supplemented with potassium and alkali to correct the fluid deficit, potassium losses and acidosis.
    explanation: The article suggests the need to correct potassium losses and acidosis, which supports low potassium and bicarbonate levels, but there is no specific mention of sodium levels.
  - reference: PMID:15367740
    supports: PARTIAL
    snippet: Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal.
    explanation: This reference discusses bicarbonate losses due to diarrhea, supporting low bicarbonate levels but does not provide direct evidence for sodium and potassium levels.
  - reference: PMID:5300879
    supports: PARTIAL
    snippet: Hypokalaemic patterns were seen in 40% of the cases in the acute stage (during rehydration).
    explanation: The study reports hypokalemia in cholera patients, which supports low potassium levels, but it doesn&#39;t provide information about sodium and bicarbonate levels.
  - reference: PMID:24952048
    supports: NO_EVIDENCE
    snippet: Vibrio cholerae...produces an enterotoxin, which causes an acute-onset diarrheal disease ranging in severity from mild to life-threatening.
    explanation: This reference describes the clinical presentation of cholera but does not provide direct evidence on the levels of sodium, potassium, or bicarbonate.
  - reference: PMID:28608260
    supports: PARTIAL
    snippet: Hyponatremia, hypokalemia, hyperkalemia...are the main internal milieu alterations in this group.
    explanation: This reference mentions hyponatremia and hypokalemia, supporting low sodium and potassium levels, but it is in the context of cirrhotic patients, not cholera.
diagnosis:
- name: Stool Culture
  presence: Positive for Vibrio cholerae
  evidence:
  - reference: PMID:32319946
    supports: SUPPORT
    snippet: The appearance of her stools and clinical findings were not suggestive of a typical case of cholera, but Vibrio cholerae was nevertheless isolated from her stools in the laboratory. The National reference center (NRC) for vibrios and cholera identified a Vibrio cholerae serogroup O1 (serotype Inaba) strain.
    explanation: This reference supports the statement that Cholera can be diagnosed by a stool culture positive for Vibrio cholerae.
  - reference: PMID:36376441
    supports: SUPPORT
    snippet: We examined the stools of 23 patients in Kolkata, who were diagnosed as cholera patients because Vibrio cholerae O1 was detected from their stools by culturing methods...
    explanation: This reference also supports the statement by indicating that stool cultures detecting V. cholerae O1 were used for diagnosis.
  - reference: PMID:6680124
    supports: SUPPORT
    snippet: A rapid test for the identification of Vibrio cholerae in stools.
    explanation: This reference supports the idea of using stool culture for diagnosing Cholera by identifying V. cholerae.
  - reference: PMID:13356145
    supports: SUPPORT
    snippet: The first portion of this study describes in detail the different aspects of stool examinations, including the collection, preservation, and pooling of specimens, macroscopic and bacterioscopic examination, enrichment methods, and cultivation on a variety of solid media.
    explanation: This reference discusses stool examinations and cultivation on solid media as methods of identifying V. cholerae, thereby supporting the statement.
  - reference: PMID:35130995
    supports: SUPPORT
    snippet: A bacterial pathogen was isolated from the diseased bullfrog intestines. The bacterium was identified as Vibrio cholerae using morphological, biochemical and 16S rRNA phylogenetic analysis.
    explanation: This reference talks about isolating and identifying V. cholerae from intestines using culture methods, supporting the statement.
- name: Rapid Diagnostic Test
  presence: Positive
  notes: Detects cholera toxin or other bacterial antigens in stool
  evidence:
  - reference: PMID:23886437
    supports: SUPPORT
    snippet: The sensitivity and specificity of RDT were 95% and 80%, respectively, with a positive predictive value of 89% and negative predictive value of 91%.
    explanation: This study from Haiti indicates that RDTs are effective and reliable for detecting cholera, supporting their use in diagnosis.
  - reference: PMID:11883125
    supports: SUPPORT
    snippet: A total of 553 stool specimens were processed from cases of acute gastro-enteritis. The sensitivity and specificity of coagglutination test was 92.77% and 95.65% respectively.
    explanation: This study supports the effectiveness of rapid diagnostic tests (coagglutination test) for cholera detection in stool samples.
- name: Darkfield Microscopy
  notes: Can show motile Vibrio cholerae in a fresh stool sample.
  evidence:
  - reference: PMID:14215188
    supports: SUPPORT
    snippet: This article describes a rapid, simple and reproducible method for detecting Vibrio cholerae in diarrhoeal patients. The method involves darkfield examination of a liquid stool specimen or a rectal swab immersed in broth and immobilization of V. cholerae by the addition of specific vibrio antisera.
    explanation: The method mentioned in the article uses darkfield microscopy to detect Vibrio cholerae in stool samples, aligning with the statement that darkfield microscopy can show motile Vibrio cholerae in a fresh stool sample.
  - reference: PMID:18024592
    supports: PARTIAL
    snippet: At the International Centre for Diarrhoeal Disease Research, Bangladesh, one-half of the rice-water stool samples that were culture-positive for Vibrio cholerae did not contain motile V. cholerae by standard darkfield microscopy and were defined as darkfield-negative (DF(-)).
    explanation: While darkfield microscopy is used to detect motile Vibrio cholerae, the study indicates that it may not always be successful in detecting motile bacteria in all stool samples, leading to &#39;darkfield-negative&#39; results in some instances.
environmental:
- name: Contaminated Water
  notes: Major source of infection
  evidence:
  - reference: PMID:29949592
    supports: SUPPORT
    snippet: We concluded that this cholera outbreak was caused by drinking lake water collected from inside the lakeshore water-collection site X.
    explanation: This study explicitly identifies contaminated water as the source of a cholera outbreak.
  - reference: PMID:33844507
    supports: SUPPORT
    snippet: Cholera is transmitted primarily by the ingestion of drinking water contaminated with fecal matter...
    explanation: This review supports the statement that contaminated water is a major environmental source of cholera infection.
  - reference: PMID:37930488
    supports: SUPPORT
    snippet: &#39;...acute diarrheal disease (ADD), typhoid, cholera, hepatitis, and shigellosis are common waterborne diseases in India.&#39;
    explanation: The abstract indicates that cholera is one of the primary diseases transmitted through contaminated water in India.
  - reference: PMID:36573678
    supports: SUPPORT
    snippet: Cholera is a diarrheal infection caused by ingested water or food contaminated with the bacterium Vibrio cholerae.
    explanation: This study confirms that cholera is caused by ingesting contaminated water, which aligns with the statement.
  environment_context:
    preferred_term: Contaminated water environment
    term:
      id: ENVO:00002186
      label: contaminated water
- name: Poor Sanitation
  notes: Facilitates the spread of the bacteria
  evidence:
  - reference: PMID:30512613
    supports: SUPPORT
    snippet: Prevention is based on universal access to water, sanitation and hand hygiene.
    explanation: The snippet suggests that poor sanitation is linked to cholera and can help prevent its spread with proper sanitation.
  - reference: PMID:20074356
    supports: SUPPORT
    snippet: In both pre- and post-monsoon seasons, SES significantly influences these patterns, likely because it is a proxy for poor water quality and sanitation in poorer households.
    explanation: The snippet implies that poor sanitation is a significant factor influencing cholera patterns.
  - reference: PMID:34961483
    supports: SUPPORT
    snippet: Drinking contaminated water from an unprotected well was associated with this cholera outbreak.
    explanation: The outbreak was associated with poor sanitation practices involving unprotected water sources.
  - reference: PMID:29903037
    supports: SUPPORT
    snippet: ranked among the world&#39;&#39;s dirtiest countries, Ghana has poor environmental sanitation and hygiene, and a lack of potable water, all of which combined have been largely blamed as the underscoring reasons for cholera outbreaks.
    explanation: The snippet explicitly states that poor sanitation and hygiene are key factors in cholera outbreaks.
  - reference: PMID:34695790
    supports: SUPPORT
    snippet: A water pipeline was damaged in the vicinity of a stream flowing from a site of open defecation.
    explanation: This incident of poor sanitation led to a cholera outbreak.
treatments:
- name: Oral Rehydration Solution (ORS)
  description: Mixture of clean water, salt, and sugar to replace lost fluids and electrolytes.
  evidence:
  - reference: PMID:8783513
    supports: SUPPORT
    snippet: For more than two decades, WHO and UNICEF have recommended a single formulation of oral rehydration salts (ORS) solution based on glucose and three salts. This product has proven safe and highly effective in treating and preventing dehydration from diarrhoea of all causes and in all age groups in worldwide use and has substantially contributed to the saving of lives in developing countries.
    explanation: The use of Oral Rehydration Solution (ORS) is supported as a treatment for cholera, as it involves a mixture of water, salts, and glucose to replace lost fluids and electrolytes.
  - reference: PMID:49561
    supports: SUPPORT
    snippet: The data contrast with the rarity of treatment failures of oral glucose-electrolyte solutions. Glucose, therefore, is preferable to sucrose for oral therapy of diarrhoeal diseases.
    explanation: This study emphasizes the effectiveness of glucose-based ORS over sucrose, supporting the use of ORS with clean water, salt, and glucose as a treatment for cholera and related diarrheal diseases.
  - reference: PMID:12562304
    supports: SUPPORT
    snippet: The mainstay of therapy of cholera patients is rehydration with oral rehydration salt solution or intravenous Ringer&#39;s lactate depending upon the degree of dehydration.
    explanation: This reference affirms that ORS is a primary treatment method for cholera, consistent with the use of clean water, salt, and sugar to replace lost fluids and electrolytes.
  treatment_term:
    preferred_term: hydrotherapy
    term:
      id: MAXO:0000458
      label: hydrotherapy
- name: Intravenous Rehydration
  description: Used for severe dehydration when rapid fluid replacement is necessary.
  evidence:
  - reference: PMID:8736618
    supports: SUPPORT
    snippet: Patients with severe dehydration should be treated intravenously, as should those patients who do not tolerate oral rehydration solution (ORS).
    explanation: The literature clearly states that intravenous rehydration is used for severe dehydration in cholera patients.
  - reference: PMID:3171790
    supports: SUPPORT
    snippet: We compared the efficacy and safety of a single polyelectrolyte solution, Dhaka solution (DS), containing 133 mmol/L sodium, 13 mmol/L potassium, 98 mmol/L chloride, and 48 mmol/L acetate with and without 139 mmol/L (25 gm/L) dextrose in the rapid (4 hours) rehydration of 67 patients with diarrhea and moderate or severe dehydration requiring parenteral fluid therapy.
    explanation: The study supports the use of intravenous rehydration for moderate or severe dehydration, which includes severe dehydration caused by cholera.
  - reference: PMID:35465904
    supports: PARTIAL
    snippet: Fluid therapy is the most important therapeutic measure in patients suffering from dehydration or hypovolemia owing to gastrointestinal diseases. The therapy should be tailored based on the patient&#39;s condition, physical examination, and diagnostic findings.
    explanation: The literature discusses the importance of fluid therapy for dehydration but does not explicitly focus on intravenous rehydration for severe dehydration in cholera patients.
  - reference: PMID:19174284
    supports: NO_EVIDENCE
    snippet: Severely dehydrated calves that are unable to suckle need intravenous fluids for effective resuscitation.
    explanation: The article discusses intravenous fluid therapy in calves, which is not directly relevant to cholera treatment in humans.
  treatment_term:
    preferred_term: hydrotherapy
    term:
      id: MAXO:0000458
      label: hydrotherapy
- name: Antibiotics
  description: Shorten the course of the illness and reduce the severity, examples include doxycycline, azithromycin.
  evidence:
  - reference: PMID:24944120
    supports: SUPPORT
    snippet: Overall, antimicrobial therapy shortened the mean duration of diarrhoea by about a day and a half compared to placebo or no treatment (MD -36.77 hours, 95% CI -43.51 to -30.03, 19 trials, 1013 participants, moderate quality evidence). Antimicrobial therapy also reduced the total stool volume by 50% (ROM 0.5, 95% CI 0.45 to 0.56, 18 trials, 1042 participants, moderate quality evidence) and reduced the amount of rehydration fluids required by 40% (ROM 0.60, 95% CI 0.53 to 0.68, 11 trials, 1201 participants, moderate quality evidence).
    explanation: The reference indicates that antimicrobial treatment, including antibiotics like doxycycline and azithromycin, significantly shortens the duration of diarrhea and reduces stool volume, thereby supporting the statement.
  - reference: PMID:11378428
    supports: SUPPORT
    snippet: Antibiotics such as tetracycline and doxycycline shorten the duration of illness but do not significantly affect overall mortality.
    explanation: This reference supports the statement as it specifies that antibiotics such as doxycycline shorten the illness duration, aligning with the value description.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Zinc Supplementation
  description: Recommended for children to reduce the duration and severity of diarrhea.
  evidence:
  - reference: PMID:18184631
    supports: SUPPORT
    snippet: Zinc supplementation significantly reduced the duration of diarrhoea and stool output in children with cholera. Children with cholera should be supplemented with zinc to reduce its duration and severity.
    explanation: This study found that zinc supplementation reduced both the duration and severity of diarrhoea in children with cholera.
  - reference: PMID:17582575
    supports: SUPPORT
    snippet: Short-course daily zinc supplementation shortens the duration (a 15%-24% reduction) and severity of the episode and is now recommended for the treatment of all episodes of diarrhea occurring among children &lt;5 years of age.
    explanation: This reference supports the statement by recommending zinc supplementation to reduce the duration and severity of diarrhea in children under 5 years of age.
  - reference: PMID:30269306
    supports: SUPPORT
    snippet: Zinc supplements are recommended in children with acute infectious diarrhea.
    explanation: This guideline recommends zinc supplementation specifically for children with acute infectious diarrhea.
  - reference: PMID:37842003
    supports: SUPPORT
    snippet: Zinc supplementation has previously been shown to improve resolution of symptoms from infectious diarrhea.
    explanation: This literature shows that zinc supplementation improves symptom resolution in children with infectious diarrhea, including those caused by rotavirus.
  treatment_term:
    preferred_term: nutritional supplementation
    term:
      id: MAXO:0000106
      label: nutritional supplementation
- name: Vaccination
  description: Oral cholera vaccines can provide protection in endemic areas or during outbreaks.
  evidence:
  - reference: PMID:22634452
    supports: SUPPORT
    snippet: This vaccine should be used in areas where cholera is endemic, particularly in those at risk of outbreaks, in conjunction with other prevention and control strategies.
    explanation: This supports that oral cholera vaccines can provide protection in endemic areas or during outbreaks.
  - reference: PMID:15193408
    supports: SUPPORT
    snippet: Retrospective analysis suggests that mass vaccination with oral cholera vaccines can be a useful adjunct tool for controlling outbreaks, particularly if implemented early in association with other standard control measures.
    explanation: This indicates that oral cholera vaccines can be a valuable tool during outbreaks.
  - reference: PMID:36255170
    supports: PARTIAL
    snippet: Efficacies of the currently licensed cholera vaccines are not optimal in endemic settings and low in children below the age of five, a section of the population most susceptible to the disease.
    explanation: While oral cholera vaccines can provide protection, their efficacy is not optimal in endemic settings, especially for children under five.
  - reference: PMID:26494426
    supports: PARTIAL
    snippet: Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists.
    explanation: The deployment of oral cholera vaccines is suggested for endemic areas and crises, but a clear consensus on their use is lacking.
  treatment_term:
    preferred_term: vaccination
    term:
      id: MAXO:0001017
      label: vaccination
review_notes: Cholera is an acute diarrheal illness caused by infection with the bacterium Vibrio cholerae. It can cause rapid and severe dehydration that can be lethal. Additional key features include &#34;rice-water&#34; diarrhea, vomiting, and electrolyte imbalances like hypokalemia and metabolic acidosis due to the massive fluid losses. Hypovolemic shock is the most severe complication. Rapid fluid and electrolyte replacement is critical.
disease_term:
  preferred_term: cholera
  term:
    id: MONDO:0015766
    label: cholera
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Cholera.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>